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The oral route is still the preferred route for the administration of active substances, being drugs, 
nutraceuticals or food supplements. Capsules are the simplest oral dosage forms, allowing the 
administration of different substances without the need of extensive formulation development. 
Nevertheless, an additional coating step is normally necessary to provide gastroresistance to solid 
dosage forms, which means added materials, equipment, time and consequently, costs. This thesis 
shows the successful development of enteric hard capsules which do not require additional enteric 
coating and subsequent mechanistic insights into polymer dissolution. The produced capsules are 
fabricated using gastroresistant polymers, guaranteeing their efficacy in bypassing the stomach without 
disintegration. The in-vitro success of these capsules may however not warrant in-vivo efficacy. This 
occurs due to the clear differences between the commonly used in-vitro dissolution media and the 
gastrointestinal fluids. During this thesis the mechanics of enteric polymer dissolution was studied, 
alongside their ionisation proprieties and the effect of different buffers in their dissolution. The pKa of 
synthetic and natural polymers was estimated using a novel application of electrophoretic light 
scattering technique, through the study of zeta potential. Both the type and the number of functional 
groups have shown to impact the estimated pKa, with phthalyl showing opposite effects to succinoyl 
groups on polymer dissolution pH and pKa. A new technique was developed for the quantification of 
HPMC-based polymers, adapted from the conventional phenol-sulfuric acid assay for carbohydrates. 
Using this technique, the dissolution rate of enteric polymers was measured in compendial phosphate 
and physiological bicarbonate buffers with varying buffer capacities. The microenvironmental pH of the 
dissolving polymers was also measured on the surface of the dissolving films using the same buffers. 
A link was observed between buffer capacity, buffer type and polymer dissolution rate, hinting at 
possible reasons for the observed poor in-vitro/in-vivo correlation. The wettability of enteric polymeric 
films was also studied using contact angle kinetics under different dissolution media, tracking contact 
angle, drop volume and basal area over a period of time. Ultimately, the data from polymer dissolution 
rate, microenvironmental pH, ionisation, pKa and wettability were correlated to better understand the 
mechanics of enteric polymer dissolution under in-vitro physiological conditions.  
Keywords: Enteric; Capsules; Zeta potential; pKa; Polymer dissolution rate; microenvironmental 
pH; buffer capacity; contact angle.   
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1.1. Capsules: a simpler formulation for per os administration 
The bioavailability of an active ingredient is greatly dependent on the route by which it is 
administered. All administration routes offer advantages and disadvantages, however, from all the 
possibilities the oral route is still preferred over others, with over eighty percent of the 50 most-sold 
pharmaceutical products in the USA and Europe being administered per os (Lennernäs and 
Abrahamsson, 2005). 
Capsules are one of the most common solid dosage forms employed for oral administration of 
active ingredients. With a global market valued at US$1.4bn in 2016 and an expected annual 
growth rate of 7.3%, the empty capsule market is predicted to worth roughly US$2.9bn in 2026 
(Future Market Insights, 2016). Capsules are relatively simple to use compared to tablets which 
need more formulation development and take longer comparatively to capsules to manufacture 
and quality control. Hard capsules present a more convenient delivery system for pharmaceuticals 
and nutraceuticals, allowing for both liquid and powder form, without the need to develop a complex 
formulation. Also, for drugs undergoing animal or clinical trials, capsules are often employed due 
to their simplicity and quick formulation turnaround for early stages of drug development 
(Murachanian, 2010). Using capsules as dosage forms for preclinical studies in animals ensures 
that no time-consuming formulation development is needed, with the test substance being readily 
loaded and administered as a capsule. Bespoke capsules are also available for various species 
for use in pre-clinical studies. The availability of specialised dosing kits aids the administration of 
capsules directly to the stomach, or to the colon through rectum (Torpac®, 2016a). Additionally, 
capsules pose a great aid not just in pre-clinical studies, but also in animal health, with veterinary 
use of capsules being a growing market. In animals, capsules may be used to accurately and more 
conveniently dose a range of materials for animal health, ensuring the entirety of the dose is 
ingested by the animal. These may be administered orally, vaginally or post-partum intrauterinally 
to cattle, horses, sheep, goats, pigs and dogs (Torpac®, 2016b).   
Hard capsules can be manufactured in different sizes and materials, depending on their purpose 
and encapsulated material (Figure 1.1). Even though other materials are used, the large majority 
of capsules are still produced using gelatine (type A, type B) from the skin/bones of pigs, cows or 
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the fish bones (Murachanian, 2010). Other materials were also developed to meet the demand for 
non-animal-origin capsules which would address a growing need for Halal, Kosher and 
vegetarian/vegan markets (Future Market Insights, 2016). The most common alternatives currently 
used are hydroxypropyl methyl cellulose (HPMC), pullulan and starch-based capsules (Capsugel, 
2019a; Qualicaps, 2019; Roxlor, 2019). Although these capsules produce a very good immediate 
release dosage form, they pose some limitations when intended for modified release applications, 
in particular gastroresistant formulations.  
 
Figure 1.1: Examples of capsule shapes and sizes, with corresponding volumes and powder capacities. Adapted 
from Murachanian (2010) and Capsugel® (2019). 
1.1.1. Capsules as gastroresistant formulations 
To protect acid sensitive substances from being degraded in the stomach, the pharmaceutical 
industry typically uses gastro resistant polymers to coat oral solid dosage forms. These coatings 
are composed of one or more polymers which behave as weak acids, being insoluble at low pH 
typically (pH 1–4), while dissolving once the pH of the media rises above 5.5 to 7, depending on 
the polymer used. The rationale behind the most common gastroresistant oral formulations is 
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therefore based on the pH changes occurring throughout the gastrointestinal (GI) tract, from the 
stomach to the colon. To resist the highly acidic pH of the stomach, a gastroresistant formulation 
has to be practically insoluble in these conditions, maintaining its integrity in stomach, yet soluble 
at intestinal pH to release the drug in proximal small intestine. The first attempt to create a 
gastroresistant formulation, exploiting the insolubility of materials in the stomach, is attributed to a 
German physician who reported clinical use of keratin coated carbolic acids pills in 1884 (Unna, 
1884). After the first glimpse of a gastroresistant solid dosage form by Unna (1884), very distinct 
approaches have been designed aiming to provide gastric protection to oral formulations.  
Typically, when a gastroresistant formulation is required, the most conventional and common 
practice is to coat the dosage forms such as tablets or pellets with gastro-resistant polymers. 
Several synthetic materials have been developed and used in the last decades for gastroresistant 
purposes, of particular importance are acrylic acid derivatives, cellulose derivatives (HPMC-P, 
HPMC-AS) and polyvinyl derivatives (PVAP), as being the most common (Cole et al., 2002). The 
most used examples of each category and their primary characteristics are summarised in Table 
1.1. 
In addition to their application in pharmaceutical industry, gastroresistant dosage forms are also 
sought after by the nutraceutical market, which is ever more demanding to include natural 
substances in the dosage form design. Hence, the industry-standard synthetic materials used to 
formulate gastroresistant pharmaceuticals cannot be used for nutraceutical applications, therefore 
creating an exceptional demand for the natural materials with gastroresistant proprieties. A critical 
review of various natural materials was performed during this project (Barbosa et al., 2017), and a 





Table 1.1: Summary table of the most commonly used commercially available synthetic enteric polymers.  
Polymer Brand name Grade DpHT 
% ionisable 













Methacrylic Acid - Ethyl 
Acrylate Copolymer (1:1) L100-55 ³5.5 46.0 - 50.6 
<0.25mm 
(95%) 320.000 
All grades are available as 
dispersions:  
- L100-55 – 30% (w/w) 
aqueous dispersion;  
- L100 and S100 – 12.5% 
(w/w) in aqueous isopropyl 
alcohol, containing 3% (w/w) 
of water. 
1 
Methacrylic Acid - Methyl 
Methacrylate Copolymer 
(1:1) 
L100 ³6.0 46.0 - 50.6 <0.25mm (95%) 125.000 2 
Methacrylic Acid - Methyl 
Methacrylate Copolymer 
(1:2) 
S100 ³7.0 27.6 - 30.7 <0.25mm (95%) 125.000 2 
        









LF / LG ³5.5 14.0 – 18.0 5µm / 1mm 18.000 F (fine) grade is the 
micronized version of G 
(granule) grade. F grade can 
be used as aqueous 
dispersion in coating, G grade 
demands organic solvents 
3 
MF / MG ³6.0 10.0 – 14.0 5µm / 1mm 18.000 3 
HF / HG ³6.8 4.0 – 8.0 5µm / 1mm 18.000 3 
HPMC phthalate 
(HPMC-P) 
   Phthalyl     
HPMCP 
HP-50 ³5.0 21.0 – 27.0 <800µm 78.000  4 









          
Polyvinyl derivatives    Phthalyl      
Polyvinyl acetate 





DpHT: dissolution pH threshold; Mw: Weight-average molecular weight;  
1: Evonik Industries (2018); 2: Evonik Industries (2012); 3: Shin-Etsu Chemical Co. (2018); 4: Shin-Etsu Chemical Co. (2002); 5: Smith, (2019); 6: Rajabi-siahboomi et al., (2018) 
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Table 1.2: Summary of natural based products for gastroresistant applications.  








Claimed to provide protection for acid sensitive ingredients using a 
delayed-release mechanism. Prone to significant inter- and intra-
subject variability in gastric emptying affecting its effectiveness. 
1 
Ethylcellulose 




Comprises EC coating containing SA, which dissolves at intestinal pH 
and forms pores in the coating layer, enabling drug release. Although 
coated tablets remain intact in 0.1M HCl (pH≤1.2) for 2h, the coating 
is not robust to resist gastric conditions pH >2.0, possibly leading to 
premature drug release in the stomach. 
2-4 
2. STARCH 
Maize starch Eudraguard® 
Natural coated 
tablets or pellets 
Based on maize starch and claimed to provide taste-masking 
proprieties and acid-resistance. However, no further information is 
available on coating composition and on mechanisms of 
gastroresistance achieved using maize starch. It is not clear if this is 








HACS is highly resilient to both gastric (0.1M, pH1.6, 2h) and neutral 
(pH 7.0. 0.1M phosphate buffer, 3h) conditions. However, it is shown 





Cast films Chemically modified shellac, where esterification with succinic 
anhydride and manipulation of annealing time allows the tailoring of 
the polymer’s dissolution pH. However, due to chemical modification, 
it potentially loses its GRAS status. 
8 
Shellac + inulin Coated tablets Coating resisted 0.1M HCl for 2 h, yet drug release was initiated when 
in phosphate buffer pH 7.4. Shellac provides the enteric resistance, 
while inulin purports to retard the drug release until the formulation 
reaches the colon. 
9 




Claimed to remain intact in 0.1M HCl for 2 h, while disintegrating at 
pH 6.8 (phosphate buffer). However, in a recent study2, a slower 
release rate was observed after the acid stage when transferred to pH 
6.8 phosphate buffer (< 50% release in 4 h) than in pH 7.4 phosphate 
buffer (80% release in 2 h). 
2,10 
4. ZEIN 
Zein + PEG-400 
or glycerol 
Coated tablets While both organic and aqueous solutions resisted 2h at pH=1.2 for 
2h, different lag times for drug release were observed when tested in 
pH 6.8 phosphate buffer. PEG-400 and glycerol were shown to 
influence the drug release, with PEG 400 formulation having a lower 





Tablet matrix Authors claim that with carboxymethyl modification, zein becomes 
soluble at pH 4.5, thus, dissolving at the pH of the small intestine, yet 
being resistant to fasted gastric pH. However, due to chemical 
modification it potentially loses its GRAS status. 
12 
1: (Marzorati et al., 2015), 2:(Czarnocka and Alhnan, 2015); 3: (Ali-Merchant et al., 2009); 4: (Young et al., 2006); 5: (Evonik 
Industries AG, 2018); 6: (Kuntz, 2016); 7: (Dimantov et al., 2004); 8: (Limmatvapirat et al., 2008); 9: (Ravi et al., 2008); 10: (Young 
and Fraser, 2010); 11: (Li et al., 2010); 12: (Yin et al., 2015). Note: This table has already been publised in (Barbosa et al., 2017). 
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Cole et al., (2002) have coated HPMC based capsules with EUDRAGIT L 30 D-55. HPMC capsules 
were used instead of gelatine ones to tackle the embrittlement of the shell and of poor coating 
adhesion due to the gelatine smooth surface. These coated capsules resisted the acid challenge 
test and released their contents (>85% released) in pH 6.8 0.05M phosphate buffer within 1.5h of 
media change. These capsules were then tested in-vivo and their path was followed in 8 healthy 
individuals using gamma scintigraphy. Results showed that capsules completely disintegrated 
after 2.4 ± 0.9h, releasing their contents in the small intestine. Although many attempts are reported 
in the literature to coat hard capsules to enable gastroresistance (Cerea et al., 2008; Cole et al., 
2002; Mahdi, 2015; Meghal et al., 2011; Reix et al., 2012) , this is yet not a common industrial 
practice (Cerea et al., 2008). This is because, the additional coating step poses as a time- and 
resource intense addition, hence increases the manufacturing costs. In addition, the quality costs 
also increase due to critical control on the coating parameters required to ensure consistency of 
the coating without compromising the integrity of the capsule shell. The smooth surface of gelatine 
capsules leads to poor adhesion of the polymeric coat, moreover the coating process often leads 
to increased brittleness of the capsules shells (Cole et al., 2002; Meghal et al., 2011). A more 
common approach is to fill enteric-coated (gastroresistant) granules or pellets into conventional 
hard gelatine capsule (Murachanian, 2010). The additional step of formulating polymeric coated 
granules or pellets is popular due to its advantages in gastric emptying over monolithic dosage 
forms and ability to tailor the drug release by using a combination of granules/pellets with varying 
coating thickness. Despite its advantages, this approach does not offer a flexible and cost-effective 
alternative to enteric coating. Therefore, if capsule shells can be formulated with built-in 
gastroresistance, they can be produced in bulk in a similar way to the standard capsules. These 
can then be supplied to pharmaceutical industries to be filled on standard high-speed capsule filing 
lines. 
Cerea et al., (2008) have reported a dry-coating method for gelatine capsules to overcome the 
problems of classic wet coating technique to protect the capsule. Dry coating briefly consists on 
the spraying of the polymer in powder form simultaneously with a plasticiser, instead of the 
conventional spraying of a solution or dispersion containing the polymer and other excipients. The 
HPMC-AS dry-coated gelatine capsules exhibited no drug release until 2h in 0.1M HCl, followed 
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by complete release in 30 min on transfer to pH 6.8 phosphate buffer. The main drawback of this 
technique was the need of extremely high coating levels (22mg/cm2) to prevent premature release 
in acid. The authors claim that the higher coating level was needed due to the less efficient curing 
process of the polymer under the dry-coating approach. A higher coating thickness was also 
reported by Mahdi (2015), who used EUD L100 to coat gelatine capsules. However, this involved 
a dip-coating method, which consists of repeated dipping and drying cycles. Although a different 
methodology was used to coat the capsules, a weight gain of 25% was still needed to completely 
warrant gastroresistance. Numerous other works employing both dip coating and spray coating 
methods reported the need for increased coating thicknesses when gelatine capsules were used 
(Meghal et al., 2011; Oliveira et al., 2013; Reix et al., 2012), which makes this approach more time 
and resource intensive. 
In addition to the issues concerning overcoating capsule shells being an additional step, the 
approach also requires capsule to be prefilled with product before coating can take place. This 
poses another limitation in the use of these capsules and would require all companies to have the 
coating capabilities. If ready-made enteric capsules can be supplied to the industry, this would 
significantly reduce the costs of producing enteric hard capsules. Moreover, the capsules with built-
in gastroresistance will have wider applications in controlling drug release and gastrointestinal 
targeting (both in human as well as in veterinary applications) as it would allow encapsulation of 
almost any drug or nutraceutical substance into empty shells, and allow their immediate use for 
R&D purposes, preclinical or clinical evaluations without extensive formulation development with 
potential reductions on the research and development cost.  
1.1.2. Truly enteric hard capsules: the “pièce de résistance” for enteric formulations 
Previous attempts to produce enteric hard capsules have been reported, however these either rely 
on an additional coating step, as referred above, or in the incorporation of a gum which would 
provide protection to acid-sensitive ingredients by a delayed-release mechanism, such as 
DRCaps™ (Marzorati et al., 2015; Smith et al., 2010). DRCaps™ do not exhibit a pH triggered 
release and instead rely on a time-delay in anticipation of timely emptying from stomach. Here the 
first problem lays regarding these formulations: the variability in gastric emptying times. Studies 
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have shown a very high intra- and inter-individual variability in gastric emptying times (Brophy et 
al., 1986; Davis et al., 1984; McConnell et al., 2008; Varum et al., 2010; Ziessman et al., 2009). 
Brophy et al., (1986) has shown that gastric emptying time of solid substances greatly varies not 
only between individuals, but also within the same individual (Figure 1.2A). Additionally, McConnel 
et al., (2008) demonstrated how gastric emptying times may be influenced by the ingestion of food 
increasing it to up to 5h (Figure 1.2B). Abrahamsson and colleagues also have shown that the 
gastric emptying greatly differs when there is a constant intake of food throughout the day, with 
gastric emptying times increasing up to more than 15h (Abrahamsson et al., 1996). This high 
variability creates an uncertainty in gastric emptying, which directly affects the efficacy of these 
products. 
 
Figure 1.2: Variability of gastric emptying time. A: Gastric emptying time from 8 different subjects measured at 
different times (from (Brophy et al., 1986). B: pH profile from one subject using the Bravo® pH capsule given 30min 
before food and a standard lunch was administered at 4h. From McConnell et al. (2008).  
EnteriCaps® is a recent example of commercially available HPMC based gastroresistant capsules 
(Fagron, 2019). Although limited information is available regarding their constitution and the type 
of HPMC used, it is mentioned that capsule shells contain a gelling agent in addition to the HPMC, 
which may swell in acidic environment and can cause premature drug release. Despite the strong 
gastroresistance claims, the capsule exhibited nearly 15% drug release in gastric stage indicating 
poor gastroprotection.  
The development of an enteric capsule should then be based on the intrinsic gastroresistance of 
its material, and not based on a delayed release. A more successful and realistic attempt to 
produce enteric capsules without the need for a coating was reported by Mehuys et al., (2005) 
using hot-melt extrusion. The authors produced HPMC AS-LG and PVAP capsules by extruding 
[A] [B]
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the polymer mixed with a plasticiser into hollow cylinders, with metal inserts in the cylindrical die 
regulating the capsule thickness (Figure 1.3).  
 
Figure 1.3: Schematic drawing of the die used for the extrusion of the capsules (left) and the resulting hot-melt 
extruded capsule. Reproduced with permission from Mehuys et al., (2005).  
The extruded cylinders were then cut into 20mm pieces, which were filled with a model drug. Hot 
pincers were used to heat-seal the tubes, producing the capsules (Figure 1.3). These vehicles 
have proved to withstand the compendial acid test (2h, 0.1M HCl), showing a quick release when 
transferred to pH 6.8 phosphate buffer. It was noticed that the test was performed using a USP-III 
apparatus using 0.2M phosphate buffer which is much stronger than usual recommended 0.05 M 
phosphate buffer by the USP and this may explain the quick disintegration of the capsules in the 
buffer. The coating thickness was shown to influence the drug release, with increasing thickness 
causing longer lag times. This effect was more distinct with HPMC AS-LG capsules, with PVAP 
capsules showing similar lag times for 0.15-0.8 mm thick capsules, with only highly thick capsules 
showing significantly longer lag times (Figure 1.4). Again, the phosphate buffer used was much 
stronger than the compendial 0.05M which may cause inaccurate drug release profiles due to the 
excessive buffer capacity of this media, leading to drug releases occurring at earlier stages.  
 
Figure 1.4: Drug release profiles of PVAP [A] and HPMC AS-LG [B] capsules with varying wall thickness after 2 h 
in 0.1M HCl and further transferred to 0.2M phosphate buffer pH 6.8. Adapted with permission from Mehuys et al., 
(2005)  
[A] [B]
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Although this technology produced capsules with suitable gastroresistance, its industrial scale 
production is fairly limited. The production of these capsules would require very specialised 
equipment and hence will be costly. Moreover, the shape and appearance of these capsules 
renders them unsuitable for oral administration; the sharp edges due to heat seal will significantly 
affect the oesophageal safety and ability to swallow these dosage forms.  
Very recently a new patent was made public with a new technique for dry coating of capsules (Zhu 
et al., 2019). Very briefly, this technique consists in the pre-heating of a capsule shell, spraying of 
the plasticiser immediately followed by the spraying of the coating powder, and then allow a curing 
time for film formation (Figure 1.5). This publication describes the successful use of EUDRAGIT 
L100-55 to form enterically coated capsules (with a coating level of 8.5%), indicating the possible 
application of this technique to produce enteric hard capsules. However, although an innovative 
technique, these coatings would have to be applied after capsule filling, creating the need of an 
added coating step and added industrial investment in equipment and method development. 
Nonetheless, this method also described the use of polymers used in extended release 
formulations, with release times up to 30h, showing its merit in tackling the issue of coating 
capsules.   
 
Figure 1.5: Schematic diagram of dry coating method. From Zhu et al., (2019). 
Capsugel® and BioCaps have developed enTRinsic™ and Bio-VXR capsules respectively, both 
claiming to provide full enteric protection without the need for functional coatings (Benameur, 2015; 
BioCaps, 2019; Capsugel, 2019b). Capsugel® mentions the use of “pharmaceutical grades of 
cellulosic enteric derivatives (100%)”, however full composition is not disclosed. Evidence of 
clinical efficacy was shown using enTRinsic™ when compared to Nexium, an Esomeprazole 
commercial dosage form which uses gelatine capsules containing enterically coated pellets 
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(Benameur, 2015). In this study, the in-vivo performance of enTRinsic™ was validated, showing 
that the pharmacokinetic profiles of both formulations showed similar rates of drug absorption, 
peak time, elimination constant and half-life. BioCaps® also does not fully disclose the composition 
of their capsules, however the associated patent (Chang et al., 2015) mentions the use of a water-
soluble polymer (pectin, propylene glycol alginate or xanthan gum), a water-soluble film forming 
polymer (gelatine, pullulan, polyvinyl alcohol, modified starch and/or cellulose ester), a gelling 
agent (gellan gum or carrageenan) and a coagulant (KCl, NaCl, CaCl2, MgCl2). These capsules 
are now commercially available, yet their clinical efficacy is not fully known. 
In this thesis, an attempt has been made to design novel formulations of enteric hard capsules 
using various commercially available enteric polymers. Enteric hard capsules with built-in 
gastroresistance were successfully produced from EUDRAGIT (L100 and S100), HPMC AS-LF 
and HP-55 meeting the compendial tests for gastroresistant dosage forms. These are described 
in detail in Chapter 2. 
1.2. Dissolution of enteric polymers: understanding the mechanics 
Gastroresistant polymers rely on a pH-trigger to initiate their dissolution, instigated by the presence 
acidic functional groups, namely carboxylic acids. These groups, as any weak acid, possess an 
associated acidity constant (Ka) and a pKa, which provides information regarding their pH-
dependant ionisation. When in solution or suspension, the pH of the surrounding media will thus 
dictate the degree of ionisation of the polymer’s acidic groups (HA). The Henderson-Hasselbalch 
equation (Equation 1.1) predicts that when [A-] = [HA], then pH=pKa. At this stage, 50% of the 
acidic groups (A-) will be deprotonated, and near complete ionisation will occur ~2 pH units above 
the pKa (Figure 1.6). The pH dependant ionisation is also responsible for the pH dependant 
dissolution of these polymers (Figure 1.6). 
!" = !$!	 + log [$
!]
[&$]   (Equation 1.1) 
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Figure 1.6: pH-dependant ionisation of a weak acid [HA] and its conjugated base [A-] based on the Henderson-
Hasselbalch equation (left) and its correspondent effect on the solubility of the compound (right). Adapted from 
Nguyen and Fogler (2005).  
This is explained by the intricate mechanics of the dissolution of the polymeric chains. Unlike non-
polymeric materials, polymer dissolution is a multistep process where two different transport 
processes occur: solvent diffusion and chain disentanglement (Miller-Chou and Koenig, 2003). 
When a compatible solvent comes in contact with a polymer, it starts diffusing into the solid glassy 
surface of the polymeric material. This causes plasticization of the polymer, leading to the 
formation of a gel-like swollen layer, interfacing with the remaining polymer and with the solvent 
(Miller-Chou and Koenig, 2003). In the case of gastroresistant polymers bearing acidic functional 
groups, when in a medium with appropriate conditions leading to ionisation, a similar mechanism 
occurs, as shown by Nguyen and Fogler (2005). When the medium starts diffusing into the 
polymer, a gel layer is formed where acidic groups deprotonate and negative charges begin to 
accumulate (Figure 1.7). The resulting charges increase the repulsion between polymeric chains, 
which in addition to the plasticization by the solvent contributes to their disentanglement out of the 
gel layer and further dissolution into bulk solution. However, the deprotonation of the acidic groups 
causes an accumulation of the released H+ ions at the boundary layer (Figure 1.7). At this stage, 
the accumulation of negative ions at the gel layer of the dissolving polymer (i.e. ionised acidic 
groups), leads to a potentially measurable charge on the surface of the dissolving polymer. 
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Figure 1.7: Representation of the dissolution of a polymer containing acidic functional groups. The encircled 
numbers represent (1) diffusion of water and hydroxyl ions into the polymer matrix to form a gel layer, (2) ionization 
of polymer chains in the gel layer, (3) disentanglement of polymer chains out of the gel layer to the polymer-solution 
interface, (4) further ionization of polymer chains at the polymer interface, (5) diffusion of disentangled polymer 
chains away from the interface toward the bulk solution (reproduced from Nguyen and Fogler (2005)). 
During the dissolution of weakly acidic polymers the ionisation of the functional groups thus leads 
to the creation of negative charges on the surface of the polymer. Arising from the ionisation of 
their functional groups, these acquired charges may vary depending on the type and amount of 
group present in each polymer. Table 1.1 highlights some of the most commonly used enteric 
polymers, and also contains the differences between the functional groups present in each 
polymer. It is clear from the specifications of each polymer that the number and type of functional 
groups directly affects the dissolution pH threshold (DpHT) of the polymer, suggesting that these 
variables directly affect the dissolution of these polymers, and therefore of the carried active 
ingredient. 
It is generally implied that polymers used in gastroresistant dosage forms targeted to the same 
area of the GI tract are interchangeable, provided that the drug release from these products in 
conventional buffers is similar. Enteric polymers may target different parts of the gut; however, 
several options exist for each area of actuation (Figure 1.8). Furthermore, each type of polymer 
possesses different functional groups, which may exhibit differences in their dissolution profiles. 
The pH dependent dissolution of these polymers generally relies on their ionisation behaviour in 
the luminal environment of the GI tract, and in-depth understanding can thus provide invaluable 
insights to understand how these polymeric materials behave in the different media. 
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Figure 1.8: Schematic showing different polymers used for enteric and reverse enteric purposes, and their targets 
in the human gastrointestinal tract; Adapted from Khutoryanskiy (2015). 
By studying the ionisation behaviour of these polymers over a range of pH, possible hints regarding 
their dissolution may be unveiled. In Chapter 3 a selection of enteric polymers was studied 
regarding their ionisation behaviour using a technique based on zeta potential, allowing further 
estimation of their pKa values and comparison with published literature. Additionally, several 
natural polymers with pharmaceutical applications were investigated using the same technique.  
1.3. In-vivo underperformance of enteric formulations: knowing the “why?”  
Despite the promising results in in-vitro compendial dissolution tests, it is common for 
gastroresistant formulations to underperform in-vivo (Al-Gousous et al., 2019; Cole et al., 2002; 
Liu and Basit, 2010). This is due to unrealistic (non-physiological) conditions of dissolution media 
used in compendial methods (USP or EP), which are mainly for quality control testing in the 
industry and do not realistically mimic gastrointestinal fluids in-vivo. 
For a substance to be absorbed and exert its effect, firstly it needs to become soluble in the medium 
where it is contained. Therefore, when administering a drug, it is of utmost importance to 
understand how and where it will dissolve in the GI tract with the composition and volume of GI 
fluids playing an essential role in the dissolution of active ingredients (McConnell et al., 2008). 
Particularly when referring to gastroresistant dosage forms, the polymeric coating is the first layer 
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between the drug and the dissolution medium. Therefore, its dissolution (or lack of) will directly 
influence the drug release. As explained in the previous section, the dissolution of enteric polymers 
is directly linked to the pH of the media, with acidic pH hindering the dissolution of the polymer. 
Nevertheless, polymer dissolution cannot simply be explained by the ionisation behaviour of these 
materials in media of different pH and the pH of the media is not solely responsible for the 
dissolution of the polymer. Spitael and Kinget (1977) have demonstrated this effect by reporting 
that the dissolution rate of EUD L100 in a pH 7.0 isotonic solution of sodium chloride was virtually 
zero, with the tested film not dissolving after 8h in this media. However, dissolution quickly occurred 
when phosphate buffer (66 mM) was used as the dissolution media. More recently, Nguyen and 
Fogler (2005) have shown that when in a medium without proton-carriers, the dissolution rate of 
both EUDRAGIT L100 and S100 was extremely low, even when tested at pH 9, which is well above 
the polymers DpHT. In the reported experiment, the presence of ammonia in the media (still at pH 
9) greatly increased the dissolution rate of these polymers. Therefore, additionally to pH, proton-
carriers also play an important role in polymer dissolution. Translating this to in-vitro release media, 
the buffering species present in solution would act as the proton-carriers, capable of accepting 
protons being generated from the ionisation of the polymeric chains, and carrying them away from 
the boundary layer, towards the bulk solution.  
Thus, when testing the dissolution of a gastroresistant dosage form, the composition of the 
dissolving media should also be of great concern, not only its pH. It is clearly demonstrated that 
the dissolution rates of ionisable drugs and of enteric coated dosage forms (based on ionisation 
processes) are strongly influenced by the buffer capacity of the fluid and its composing species 
(Aunins et al., 1985; Nguyen and Fogler, 2005; Ozturk et al., 1988b; Ramtoola and Corrigan, 
1989). Thus, it is imperative that the media used to simulate GI fluids are as similar as possible to 
the physiological ones, with the use of compendial phosphate buffers as mimicking media of the 
gut being a dramatic oversimplification as the ionic composition and the buffer capacity of this 
buffer is not remotely close to the one found in biological fluids in the intestine.  
In addition to the effect of the buffer constitution and buffer capacity in the dissolution of ionisable 
drugs and enteric coatings, the surface tension also plays an important part due to its influence on 
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the wettability. This role is majorly played by pepsin in the stomach and by bile salts and 
phospholipids in the intestine (McConnell et al., 2008). In an attempt to consider these elements, 
more complex gastric and intestinal fluids were developed taking in consideration the differences 
of the fasted and fed state.  
Initial attempts were made by Dressman (1998) and Galia (1998) to modify the pharmacopoeial 
fasted state simulated gastric fluids (SGF), by the addition of sodium lauryl sulphate (SLS) and 
Triton-X100 to decrease surface tension of the dissolution media. However both these 
modifications were later shown by Vertzoni et al.(2005) to overestimate gastric dissolution, who 
proposed a fasted state simulated gastric fluid (FaSSGF) containing pepsin and low amounts of 
bile salt (Sodium taurocholate) and lecithin (Table 1.3). This fluid is more similar to the constitution 
of fluids obtained from in-vivo samples than the SGF suggested by USP and the versions with 
synthetic surfactants (SLS and Triton) and shows better correlations to the physiological medium 
(Vertzoni et al., 2005).  
Table 1.3: Composition and physicochemical properties of simulated gastric fluid (SGFSLS and SGFTriton) suggested 
by USP, the fasted state simulated gastric fluid (FaSSGF) and the in-vivo data of gastric contents in the fasted 
state. Adapted from (Vertzoni et al., 2005).  
Composition SGFSLS SGFTriton FaSSGF In-vivo (fasted state) 
Sodium lauryl sulphate (%, w/v) 0.25 – – – 
Triton-X100 (%, w/v) – 0.1 – – 
Pepsin (mg/mL) – – 0.1 ~ 0.8 
Sodium taurocholate (µM) – – 80 ~ 80 
Lecithin (µM) – – 20 – 
Sodium chloride (mM) 34.2 34.2 34.2 68 ± 29 
Surface tension (mN/m) 33.7 32.0 42.6 41.0 ± 6.0 







pH (adjusted with HCl) 1.2 1.2 1.6 1.4 ± 2.1 
Regarding the fed state stomach, the ideal media should have similar physicochemical and 
nutritional proprieties of a meal and allow manipulations to simulate different stages of digestion 
and stomach secretions. Traditionally whole cow’s milk (3.5% fat) has been used to formulate 
postprandial gastric media, due to its similarity in terms ratio of carbohydrate/fat/protein, pH (6.5–
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6.6) and physicochemical properties to homogenized and undigested standard breakfasts (Klein 
et al., 2004). 
Three media were developed by Jantratid and colleagues (Jantratid et al., 2008) to mimic different 
stages of food digestion in the stomach (Table 1.4). These media have the particularity of 
containing different proportions of UHT milk in their composition, mimicking the differences in the 
amount of protein and fat at different dissolution stages. The middle stage media was considered 
the default fed state simulated gastric fluid (FeSSGF), being suggested as the best option to 
globally simulate the fed state of the stomach. Although it cannot represent all meal types at all 
times of the postprandial phase, this is a broad representative of fed conditions in the stomach 
(Jantratid et al., 2008). An alternative to the use of UHT milk has been exploited, using a modified 
artificial liquid meal (Ensure® Plus with addition of 0.45% pectin), which has demonstrated to be 
more similar to the standard FDA breakfast (Klein, 2010).  
Table 1.4: Composition and physicochemical properties of simulated gastric fluids considering different stages of 
the fed state, including the Fed State Simulated Gastric Fluid (FeSSGF). Adapted from (Jantratid et al., 2008). 
Composition Early Middle (FeSSGF) Late 
Sodium chloride (mM) 148 237.02 122.6 
Acetic acid (mM) – 17.12 – 
Sodium acetate (mM) – 29.75 – 
Ortho-phosphoric acid (mM) – – 5.5 
Sodium dihydrogen phosphate (mM) – – 32 
UHT-Milk/ Acetate Buffer 1:0 1:1 1:3 
Osmolality (mOsmol/kg) 559 400 300 
pH 6.4 5 3 
Buffer capacity (mmol/L/∆pH) 21.33 25 25 
Concerning the intestinal phase, also fasted and fed simulated intestinal fluids were developed 
and improved (Dressman et al., 1998; Galia et al., 1998; Jantratid et al., 2008; Khoshakhlagh et 
al., 2015; Vertzoni et al., 2004).  
Early in 1998, Dressman and co-workers firstly proposed a simulated intestinal fluid for both fasted 
(FaSSIF) and fed (FeSSIF) states (Dressman et al., 1998). Jantratid et al. (2008) later adjusted 
this medium due to the unrealistic quantities of bile salts and lecithin, and also replaced the 
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phosphate for maleate to obtain better correlation to the physiological fluid (FaSSIF-V2, vide Table 
1.5). Bearing a pKa2 of 6.27, maleate buffer is suitable for the required pH range of 5.4 to 6.5, 
allowing the inclusion in both fasted and fed state media (vide Table 1.5 and Table 1.6), yet 
maintaining the osmolality within physiological values (Jantratid et al., 2008). These changes were 
further validated by Söderlind and colleagues, who performed solubility studies in several neutral 
drugs including atovaquone, carbamazepine, cyclosporine, danazol, among others using the 
FaSSIF, FaSSIF-V2, pH 6.5 phosphate buffer and real human intestinal fluid (Söderlind et al., 
2010).  
Table 1.5: Composition and physicochemical properties of the first proposed fasted state simulated intestinal fluid 
(FaSSIF) and it’s updated and more biosimilar version (FaSSIF–V2). Adapted from Jantratid et al. (2008) and Klein 
(2010). 
Composition FaSSIF  
(Dressman et al., 1998) 
FaSSIF–V2  
(Jantratid et al., 2008) 
Sodium taurocholate (mM) 3 3 
Lecithin (mM) 0.75 0.2 
Sodium dihydrogen phosphate (mM) 28.65 – 
Maleic acid (mM) – 19.12 
Sodium Hydroxide (mM) q.s. ad pH 6.5 34.8 
Sodium Chloride (mM) 105.85 68.62 
pH 6.5 6.5 
Osmolality (mOsmol/kg) ~270 180 ± 10 
Buffer capacity (mmol/L/∆pH) ~12 10 
Recently, a study by Khoshakhlagh and colleagues aimed to improve the FaSSIF medium by 
adding cholesterol in order to increase the similarities to the human intestinal fluid (Khoshakhlagh 
et al., 2015). The group prepared several media with different amounts of cholesterol aiming to 
mimic the differences in the bile fluids of male and female and also in cases of disease. The study 
showed improved solubility for the tested hydrophobic drugs, thus recommending the use of this 
media for in-vitro studies regarding these type of drugs in order to improve the IVIVC. For the 
development of fed state intestinal fluids, resembling the rationale for FeSSGF, the same group 
(Jantratid et al., 2008) developed three different fed state simulated intestinal fluids (FeSSIF), 
representing early, middle and late stages of the digestion process (Table 1.6). 
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However, such as for the gastric media, it is occasionally more practical to select a medium that is 
an overall representation of the intestine in postprandial situations. Unlike for the gastric media,  a 
different “global” FeSSIF was developed (FeSSIF–V2), combining the postprandial changes in pH, 
buffer capacity, osmolality, bile components concentration and using physiologically relevant 
concentration of lipolysis products (Jantratid et al., 2008). 
Table 1.6: Composition and physicochemical properties of simulated intestinal fluids considering different stages 
of the fed state and a “global” representation of the intestinal fed state (FeSSIF–V2). Adapted from Jantratid et al. 
(2008). 





Sodium taurocholate (mM) 10 7.5 4.5 10 
Lecithin (mM) 3 2 0.5 2 
Glyceryl monooleate (mM) 6.5 5 1 5 
Sodium oleate (mM) 40 30 0.8 0.8 
Maleic acid (mM) 28.6 44 58.09 55.02 
Sodium Hydroxide (mM) 52.5 65.3 72 81.65 
Sodium Chloride (mM) 145.2 122.8 51 125.5 
pH 6.5 5.8 5.4 5.8 
Osmolality (mOsmol/kg) 400 ± 10 390 ± 10 240 ± 10 390 ± 10 
Buffer capacity (mmol/L/∆pH) 25 25 15 25 
Despite the development of all these media, and the improvement of the buffers by replacing 
phosphate by maleate, the intestinal fluids do not contain this buffer species, with the main 
buffering specie being bicarbonate (Liu et al., 2011). As an attempt to create a more biorelevant 
buffer, Liu and colleagues have developed a variation of the commonly used Hanks Buffer 
(mHanks buffer), which almost perfectly mimics the jejunal fluid, in terms of composition and 
concentration, and also in terms of buffer capacity (Table 1.7). However, bicarbonate buffers are 
highly unstable, with the evaporation of CO2 leading to the continuous increase in the pH. 
Therefore, an apparatus was designed to control and maintain the pH of bicarbonate buffers during 
dissolution tests (Merchant et al., 2013). Figure 1.9 shows the apparatus developed to 
automatically monitor and control the pH of bicarbonate buffers by actively sparging CO2 into the 
dissolution media, allowing the stability of the buffer throughout dissolution tests.   
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Table 1.7: Comparison of the ionic composition (mM) and buffer capacity of jejunal fluid and phosphate and 
mHanks media. Reproduced with permissions from Liu et al., (2011). 
Composition Human jejunal fluid 
Phosphate buffer 
(0.05M, pH 6.8) 
mHanks buffer 
(pH 6.8) 
Bicarbonate 7.1 Not present 4.17 
Phosphate 0.8 50 0.8 
Potassium 5.1 50 5.8 
Sodium 142 29 142 
Chloride 131 Not present 143 
Calcium 0.5 Not present 1.3 
Magnesium Not present Not present 0.8 
Buffer capacity (mmol/L/∆pH) 3.2 23.1 ± 0.3 3.1 ± 0.2 
 
Figure 1.9: Auto pH™ system, an apparatus for dissolution testing of solid dosage forms, includes a chamber (12) 
for holding a solvent medium (18), in the preferred embodiment a bicarbonate based buffer system. The apparatus 
also includes a pH probe (66) which is connectable to a supply of carbon dioxide (32, 34), as well as to a supply of 
helium (40), the supplies being controlled by a control unit (50). The control unit (50) monitors changes in pH of the 
solvent medium (18) and feeds pH increasing or pH reducing gas from the supplies (32, 34, 40) into the chamber 
(12). The control unit (50) is able to maintain a uniform pH during testing or to provide a dynamically adjustable pH 
during testing, Adapted from Merchant et al., (2013).  
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To show the importance of the use of a proper dissolution medium to assess the dissolution of 
enteric coated products, Liu and colleagues performed dissolution studies on prednisolone coated 
tablets (Liu et al., 2011). These tablets were coated with different well-known enteric polymers and 
were tested using both phosphate and mHanks buffers. Figure 1.10 noticeably shows the 
difference in using phosphate or bicarbonate buffer systems during the dissolution assay. When 
using phosphate buffer (Figure 1.10A), all coatings seem to start disintegrating shortly after being 
exposed to the medium, with a full release of the drug occurring before 90 min of exposure (210 
min of dissolution test). However, the mHanks buffer (Figure 1.10B) provides very distinct results. 
Using this buffer, the release onset occurs at least after 30 min of exposure (up to 60 min) with all 
coatings. Furthermore, significant differences in the release patterns can be observed with lower 
slopes observed for bicarbonate, representing a slower release of the drug, which indicates that 
the different buffers affect not only the onset of drug release, but also its release rate.  
 In Chapter 2 clear differences are shown in drug release from the produced enteric capsules in 
phosphate and bicarbonate buffers and Chapter 4 highlights the differences these two buffers exert 
in the dissolution rate of the tested enteric polymers.  
The realization that the dissolution media explains why formulations perform poorly in-vivo despite 
successful in-vitro results answers only part of the enigma. More biorelevant dissolution media as 
the ones described may indeed help better predict the behaviour in-vivo, however it is necessary 
to comprehend what rules the dissolution of enteric polymers, how their pH dependent solubility is 
affected and what impacts their dissolution rate both in-vitro and in-vivo.  
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Figure 1.10: Drug release coated prednisolone tablets in 0.1M HCl for 2 h (data not shown) followed by pH 6.8 
phosphate buffer (A) and mHanks bicarbonate buffer (B). Adapted from Liu et al., (2011).  
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1.3.1. Controlling the pHm at the boundary layer: the ultimate regulator of dissolution 
The microenvironmental pH (pHm) is key for the dissolution of substances with pH-dependant 
solubility. The formation and manipulation of the microenvironment of different pH surrounding a 
dissolving substance has been exploited by different authors, aiming to improve or modulate drug 
dissolution in solid oral dosage forms (Doherty and York, 1989; Farag Badawy and Hussain, 2007; 
Siepe et al., 2006; Taniguchi et al., 2014; Tran et al., 2008).  
Taniguchi and co-workers (2014) modulated the dissolution behaviour of various drugs by 
controlling the pHm. Krieg and colleagues also refer the importance of this microenvironment, 
measuring the surface pH of dissolving drugs in media at different pH and buffer concentrations 
(Krieg et al., 2014). Later, Al-Gousous and co-workers (2019) deepened this understanding by 
showing that the buffer concentration greatly influences the pHm, indicating that the pH and the 
concentration of the buffering species ultimately regulate the dissolution rates.  
When referring to enteric polymers, which mainly rely on pH to initiate their dissolution, it is 
necessary to consider also the importance of both buffer type and buffer capacity in regulating 
dissolution. When in a medium with a pH higher than the polymer’s dissolution pH threshold, 
ionisation of the acidic groups takes place, leading to the disentanglement of the polymer chains, 
and polymer dissolution. As previously mentioned, during early stages of dissolution, there is an 
influx of medium (containing water, hydroxyl ions and constituent salts) towards the polymeric 
matrix, which causes a gel layer to form due to ionisation of the polymer (Miller-Chou and Koenig, 
2003). As the polymer ionises, protons are released and diffuse from the gel layer to the bulk 
solution. The layer between the gel layer and the bulk solution through which the generated protons 
diffuse is thus denominated “boundary layer”. The continuous generation of H+ ions caused by the 
ionisation of the polymer will eventually lead to their accumulation in this layer (Nguyen and Fogler, 
2005), causing the lowering of the pH in this area. If the accumulation is extensive and the pH 
decreases enough to halt the ionisation (e.g. lowering near two pH units below pKa), the dissolution 
of the polymer is dampened. 
The accumulation of H+ ions creates a microenvironment in this layer, where the pH is lower than 
the bulk pH. These H+ are neutralised by the buffer species in solution, however the rate of this 
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neutralisation will depend on the buffer capacity of the medium. Therefore, the accumulation of H+ 
ions in the diffusion layer, and consequently the pHm will be highly dependent of the buffer capacity 
of the medium in which the polymer is dissolving (Figure 1.11). Therefore, the removal of the 
produced H+ ions from this layer is key to the continuation of the dissolution process. This 
elimination occurs through buffering species present in the surrounding dissolution media. In-vivo 
this is occurring through naturally present buffering species in the intestinal fluid (bicarbonate and 
phosphate ions). When referring to in-vitro testing, the buffering species will vary according to the 
medium used (e.g. phosphate buffer, mHanks buffer, Krebs buffer, FaSSIF, FeSSIF, etc.). 
Nevertheless, and more importantly, the rate at which the protons are removed from the boundary 
layer is directly related to the buffer capacity of the medium. The control of the pHm should be 
discussed not in terms of the buffer concentration, as was done by Al-Gousous et al.,(2019), but 
the buffer capacity of the medium, which by providing sufficient buffering species in solution 
neutralises the H+ ions being generated during polymer dissolution (Figure 1.11). Although buffer 
capacity is indeed proportional to the concentration of the buffer and most times is more convenient 
to mention buffer concentration values, it is the chemistry of each buffer species and its capacity 
to neutralise changes in pH that influences the dissolution of different materials, particularly 
ionisable substances (Sheng et al., 2009). Different buffering species with the same molarity may 
generate different buffer capacities, and consequently may exert distinctive control over the pHm. 
Hence, buffer capacity should be addressed as the regulator of polymer dissolution. 
The pHm of dissolving enteric polymers has been mathematically modelled by Ozturk et 
al.,(1988a). Ozturk and colleagues proposed a mathematical model to describe the dissolution of 
enteric polymers and the release kinetics of weakly-acidic drugs from gastroresistant oral solid 
dosage forms. Later, the pHm was not just modelled, but indeed detected and measured in enteric 
polymers by Harianawala et al.,(2002). Their method was based on a previously described idea 
for the detection of a microviscous layer formed during the dissolution of polyethylene glycol 
(Bogner et al., 1997), and was hypothesised that a similar region of higher viscosity could be 
detected on a dissolving enteric polymer (the gel layer), where protons would accumulate, leading 
to the possible measurement of the pH in this region (Harianawala et al., 2002).  
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Figure 1.11: Schematic representation of the dissolution process of enteric polymers in high and low buffer capacity 
media, highlighting the difference in the accumulation of protons at the boundary layer. 
The investigation performed by Al-Gousous et al.,(2019) regarding the effect of buffer 
concentration on the dissolution of enteric dosage forms has revealed that the effect of buffer 
concentration was considerably stronger than the bulk pH of the buffer (tested between pH 6.0 and 
6.8). The authors have compared between the compendial 50 mM pH6.8 phosphate buffer and 
other bicarbonate buffers at different molarities. However, a direct comparison between phosphate 
and bicarbonate buffers at similar buffer capacities is still lacking, highlighting how the buffer 
chemistry and the buffer capacity indeed affect the dissolution of enteric coatings. Chapter 4 of 
this thesis delves into the effect of the buffer type and capacity on the dissolution rate of enteric 
polymers. The dissolution rate and the pHm of different enteric polymers was determined using 
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1.4. Thesis overview 
This thesis commences (Chapter 1) by critically appraising the current state of the art in achieving 
gastroresistance, reviewing various polymers employed and the current understanding on how 
these formulations dissolve under in-vitro and in-vivo settings. Chapter 2 presents the development 
of enteric hard capsules which do not require any additional coating. The capsules were produced 
using acrylic- and cellulose-based enteric polymers commonly used in the industry for overcoating 
solid dosage forms. The novel capsules with built-in gastroresistance were filled with a model drug 
and successfully passed the compendial test for gastroresistant dosage forms. Additionally, these 
formulations were also tested using physiological bicarbonate-based buffers and the chapter also 
discusses the differences in drug release in compendial and physiological buffers.  
Acknowledging the differences in drug release from different buffers and the underperformance of 
compendial release media in predicting in-vivo behaviour of enteric dosage forms, a multitude of 
experiments were designed in an attempt to better understand the polymer ionisation and 
dissolution.  
The dissolution of enteric polymers involves (and is truly influenced by) the ionisation of the acidic 
functional groups on the polymer chains. Chapter 3, therefore, explores the ionisation behaviour 
of commonly used enteric polymers using a novel technique based on zeta potential 
measurements over a range of pH. The chapter includes the basis for method development and 
necessary validations performed. The pKa of various enteric polymers was then measured using 
this technique. Additionally, the method was also applied to various natural polymers of 
pharmaceutical interest to study their ionisation behaviour and, where applicable, a pKa value was 
also determined.  
Following the ionisation studies, enteric polymer dissolution was explored further in Chapter 4 to 
look into mechanistic insights. The influence of buffer type and buffer capacity was studied on the 
dissolution rate of these polymers, the microenvironmental pH (pHm) and contact angle kinetics 
were also studied. During this work a new method was developed for the quantification of cellulose-
based enteric polymers to measure the dissolution rate of these polymers. The technique may be 
used to simultaneously study polymer and drug dissolution from gastroresistant solid dosage 
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forms. The obtained results highlight the effect of both buffer capacity and polymer type on 
dissolution of these materials. The type of buffer used, and the buffer capacity actively influenced 
the experienced pHm for these polymers, ultimately influencing their dissolution rate. The studies 
in this chapter explain the drug release profiles from the capsules produced in Chapter 2 and 
revealed how polymer dissolution rate directly affected the drug release.  
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1.5. Aims and Objectives 
The main aims of this thesis include: 
o To develop a novel formulation for enteric hard capsules  
This included the design and validation of novel hard capsules with built-in 
gastroresistance, which do not require a further coating step (Chapter 2).  
o To study the ionisation dependant solubility of enteric polymers 
The objectives included the development of a method for the estimation of the pKa of 
enteric polymers based on zeta potential. This method was developed and validated in 
Chapter 3 using various synthetic polymers commonly used in the industry to formulate 
gastroresistant dosage forms and was then applied to study the ionisation behaviour of 
various natural polymers. 
o To understand the factors governing the polymer dissolution and drug release from 
gastroresistant dosage forms 
Chapter 4 involved the development of a methodology which would allow the quantification 
of enteric polymers to study the polymers dissolution rates. Secondly, the 
microenvironmental pH (pHm) of dissolving polymers was measured under different 
dissolution media and the contact angles kinetics of the same polymers were investigated. 
Finally, various factors governing dissolution of enteric polymers was analysed and 
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2.1. Introduction 
As mentioned in Chapter 1, the production of gastroresistant formulations using hard capsules has 
been attempted either by coating granules with enteric polymers and loading them in standard 
gelatine capsules, or by directly attempting to coat the capsules with said polymers. As stated in 
Section 1.1.1, although extensively reported, coating hard gelatine capsules is not a standard 
industrial practice. Therefore different companies have recently reported the development of truly 
enteric hard capsules, which do not require an additional coating step (BioCaps, 2019; Capsugel, 
2019b). The constitution of these capsules is expectedly not disclosed and therefore these are not 
easily available for small scale clinical studies or for different types of studies involving polymer 
dissolution.  
Hard capsules are typically industrially produced in large scale, through the use of specific 
equipment. Firstly, a solution of the capsule forming material is prepared, e.g. a formulation 
comprised of gelatine and other additives (colouring agents, plasticisers, preservatives, etc.). In 
the typical industrial process for the production of capsules, capsule pins are used as moulds for 
both capsule bodies and caps. These pins are dipped in the warm gelatine formulation and are 
then moved by a conveyor belt through a drying chamber, allowing the capsule shells to dry and 
harden at specific temperature and humidity. The hardened shells are then removed from the pins, 
cut to adequate sizes and assembled to form a final hard capsule. This is a process that demands 
specific equipment (such as the capsule moulds), and therefore is not easily reproduced in small 
scale research laboratories at a much smaller scale.  
However, the ease of access to enteric hard capsules would be beneficial not only to study new 
pharmaceutical entities in small scale trials, but also in the study of the dissolution of enteric 
polymers, and how it is affected by a multitude of factors, such as pH, buffer type, buffer capacity, 
among others. The possibility of producing capsules in small scale using known and new materials 
would allow the testing of new enteric formulations and also help to increase the understanding of 
polymer dissolution and how this affects drug release from gastroresistant dosage forms.  
Thus, in this work, gastroresistant capsule shells were developed using three of the most 
commonly used polymers in pharmaceutical industry for formulating gastroresistant dosage forms: 
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hydroxypropyl methyl cellulose acetate-succinate (HPMC-AS) and hydroxypropyl methyl cellulose 
phthalate (HPMC-P) and Methacrylic Acid - Methyl Methacrylate (EUDRAGIT®). Additionally, 
capsules based on acrylic polymers such as EUDRAGIT are not yet reported in the literature and 
as such, the production of EUDRAGIT enteric capsules was a novelty.  
2.2. Materials and Methods 
2.2.1. Materials 
The acrylic (EUDRAGIT® L100 and S100) and cellulose based (HPMC AS-LF and HP-55) enteric 
polymers were provided in-kind as samples from Evonik Industries AG (Darmstadt, Germany) and 
Shin-Etsu (Chiyoda, Japan), respectively and their properties are summarised in Table 1. Sodium 
hydroxide, hydrochloric acid (37%) and ethanol were purchased from Fisher Scientific 
(Loughborough, United Kingdom). Gelatine (~300g Bloom, Type-A, porcine skin), Glycerol, lactose 
monohydrate, triethyl citrate and trisodium phosphate dodecahydrate ≥98% were purchased from 
Sigma-Aldrich (Dorset, United Kingdom). Ac-Di-Sol® SD-711 (croscarmellose sodium) and 
Kollidon® 30 (povidone) were provided in kind by FMC Health and Nutrition (Ireland). Prednisolone 
was purchased from Severn Biotech, Ltd (Kidderminster, United Kingdom).  
Table 2.1: Enteric polymers used in this study and their characteristics. 











Aqoat® AS-LF ³5.5 
Shin-Etsu Chemical Co., Ltd., 
Japan 
Hypromellose 
phthalate - HP-55 ³5.5 
2.2.2. Design and manufacture of capsule pin bars 
For the production of capsules, two sets of pins (capsule moulds) were fabricated from 
pharmaceutical grade stainless steel (316SS) rods with different dimensions: one for the body of 
the capsule, and a second for the cap. Capsule pin bars were designed and manufactured in-
house for a standardized capsule size “00” (Figure 2.1), according to the reported dimensions for 
this size (Podczeck and Jones, 2004). 
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Figure 2.1: Schematic representation of capsule pin bars with the designed dimensions and of the formed capsule. 
2.2.3. Production of hard capsules  
To firstly develop the capsule manufacturing procedure, gelatine was used as a pilot material due 
to its well-known gelling proprieties and its ease of use. Using gelatine as a model material, the 
manufacturing procedure was developed and tested, until a hard capsule was obtained. A solution 
of 60% (w/w) gelatine in water was used with the gelatine solution being magnetically stirred and 
kept at 65ºC throughout the capsule production process. To produce the capsule shells, the pins 
from Figure 2.1 were immersed into the warm gelatine formulation, then withdrawn and inverted. 
The gelatine solution was then allowed to dry until the shells hardened, forming the cap and body 
of the capsule. The caps and bodies were then removed from the pins, cut to the desired length 
and assembled to form a finished capsule. The same manufacturing method was applied when 
experimenting on the enteric polymeric formulations. 
2.2.3.1. Optimisation of enteric capsules  
Capsules were formulated using different concentrations of polymer (20-30%) plasticised either 
with triethyl citrate (TEC) or glycerol at different concentrations (20-40%). The tested formulations 
are summarised in Table 2.2. These formulations were achieved based on background screening 
using capsules containing gelatine only, and a mixture of gelatine and enteric polymer. These 
results are not shown, as they were part of an MSc student’s project, supervised during this PhD 
project. These formulations allowed both to improve the manufacturing technique and also to 
understand the differences in the hardening process of gelatine and polymeric capsules. Following 
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this, formulations containing only polymeric material only were pursued further and are discussed 
in this thesis.  
The polymer concentration was key in obtaining a capsule with appropriate thickness that could 
be easily removed from the pins. The polymer concentration also governs the viscosity of the 
prepared solution. An optimum viscosity is essential for the polymer to adhere to the pins during 
the drying process and produce a uniform capsule of an appropriate shape. The type and 
concentration of plasticiser impacts upon the capsule shell elasticity and prevents brittleness. 
Table 2.2: Composition of the tested formulations to produce gastroresistant capsule shells. 
Formulation ID Polymer %a Plasticiser %b Solvent 
1.1 
HP-55 
20.0 Glycerol  20.0 
Ethanol : Water  
(80:20c) 
1.2 20.0 TEC  20.0 
1.3 22.5 Glycerol  20.0 
1.4 22.5 Glycerol  30.0 
2.1 
AS-LF 
20.0 Glycerol  20.0 
Ethanol : Water  
(80:20c) 
2.2 20.0 TEC  20.0 
2.3 22.5 Glycerol  20.0 
2.4 25.0 Glycerol  20.0 




20.0 Glycerol 20.0 
Ethanol : Water 
(97:3c) 
3.2 20.0 TEC 20.0 
3.2 25.0 TEC 20.0 
3.4 25.0 TEC 30.0 
3.5 27.5 TEC  20.0 
3.6 27.5 TEC  30.0 
3.7 27.5 TEC 40.0 
4.1 EUD 
S100 
25.0 TEC 40.0 Ethanol : Water 
(97:3c) 
4.2 27.5 TEC 40.0 
HP-55 = Hypromellose phthalate-55; AS-LF = Hypromellose acetate succinate – LF;  
EUD L100 = EUDRAGIT L100; EUD S100 = EUDRAGIT S100; TEC = Triethyl citrate. 
a: based on total weight, b: based on polymer weight, c: based on solvent weight 
 
2.2.4. Tensile studies of produced capsules 
The mechanical properties of the polymeric materials used in the production of the capsules were 
studied using a TA.XT2 Texture analyser (Stable Micro Systems Ltd, Surrey, UK) equipped with 
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tensile grips (tensile mode) and a cylinder probe (P/0.5’’R; compressive mode). The films of each 
polymer were produced with the same formulation used for the capsules, casted on a flat surface 
and allowed to dry in the same conditions as the capsules would be. The thickness of the films 
was controlled by calculating the area of the surface where the film was casted, and systematically 
using a similar ratio of mass of polymer/area as it would be when using each formulation to produce 
the capsules. The films were then cut in dog-bone shaped pieces according to DIN EN ISO 527-2 
for the determination of tensile properties, consisting of a rectangular testing area of 40x8mm. For 
each sample an average thickness was acquired, and the stress area was calculated. The tests 
were performed at a speed of 0.5 mm/sec, at 20 °C, with 10 replicates per sample. The slope of 
the linear range of the obtained stress vs. strain curves (tensile mode) corresponds to the Young’s 
modulus for the respective polymeric films. 
2.2.5. Prednisolone filled gastroresistant capsules  
All prepared capsules were filled with prednisolone granules prepared by wet granulation. Briefly, 
the formulation contained prednisolone (5%), lactose monohydrate (88%), Kollidon® 30 (5%), Ac-
Di-Sol® SD-711 (2%). The ingredients were mixed using a Caleva Multi Lab (Caleva Process 
Solutions Ltd, England). The wet mass was then extruded and the extrudate was spheronized 
using the corresponding module from the Caleva Multi Lab, followed by drying at 60 °C. The 
granules were then filled manually into capsule shells to an equivalent of 10 mg prednisolone per 
capsule.  
2.2.6. Drug release from prednisolone-filled gastroresistant capsules 
The drug release from prednisolone-filled capsules was tested using USP-II dissolution apparatus 
(PT-DT70 Dissolution Apparatus, Pharma Test Apparatebau AG, Germany). Six capsules were 
tested for each successfully prepared formulation following the USP <711> Dissolution monograph 
for delayed-release dosage forms. Briefly, AS-LF, HP-55 and EUD L100 capsules were firstly 
tested in 0.1M HCl (pH 1.2) for 120 min at 37°C, followed by pH 6.8 phosphate buffer (0.05M 
Na3PO4, pH adjusted with 1M HCl / 1M NaOH) or pH 6.8 mHanks buffer (Liu et al., 2011) (136.9 
mM NaCl, 5.37 mM KCl, 0.812 mM MgSO4·7H2O, 1.26 mM CaCl2, 0.337 mM Na2HPO4·2H2O, 
0.441 mM KH2PO4, 4.17 mM NaHCO3, pH adjusted to 6.8 using CO2 (g)). Capsules of EUD S100 
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were also produced and tested, however, since this polymer was designed to target the distal gut, 
the dissolution testing included two media changes to reflect the aboral changes in pH down the 
intestine. The capsules were firstly tested in 0.1M HCl (pH1.2 for 2 hours) to represent gastric 
conditions followed by a change to pH 6.8 (for 4 hours) to simulate the pH of the proximal small 
intestine. Finally, the pH was adjusted to 7.4 for the rest of the experiment simulating the distal 
small intestine. Like other capsules, the test was conducted in both phosphate and mHanks 
buffers, as described above in this section. For mHanks buffer, the pH change from pH 6.8 to 7.4 
was performed in-situ by sparging helium and the pH was then maintained during the dissolution 
studies by sparging CO2, as described by Liu et al. (2011). 
The release of prednisolone from HPMC AS-LF and EUDRAGIT capsules was quantified using an 
in-line UV spectrophotometer (Unicam UV/Vis UV2-200 spectrophotometer) at a wavelength of 
246 nm. For the capsules containing HP-55, the release of the drug was quantified by HPLC-UV 
due to interference between the UV absorbance of the polymer and drug. The HPLC-UV system 
used was a Shimatzu LC-20AT with SIL-20A autosampler and an SPD-20AV UV detector. The 
samples were filtered through 0.2 µm syringe filters (Sartorius™ Minisart™ High Flow) and injected 
into a reverse phase C8 (5 µm particle size, 4.6x150 mm) column (Waters, Massachusetts, USA). 
The column was heated to 40°C and the mobile phase consisted of a mixture of 
water:tetrahydrofuran:methanol (68.8:25:6.2 v/v) flowing at 1.5 mL/min. Prednisolone was 
detected at 254 nm, at retention time of 2.7 min (Liu et al., 2011). 
2.3. Results and discussion 
2.3.1. Production of hard capsules 
The use of gelatine allowed for a quick testing and development of a capsule manufacturing 
technique. Gelatine’s gelling characteristics ensures that capsules are easily produced without the 
need for extended know-how and experience. Hence, the first gelatine capsules were produced 
as described in section 2.2.3 using the in-house designed capsule pins (Figure 2.2).  
The challenge was then to transfer the methodology from using gelatine to an enteric polymer. The 
hardening of gelatine is based on its gelling proprieties, i.e. its rheological characteristics. Gelatine 
softens with increasing temperatures and hardens when the temperature decreases. This 
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behaviour is exploited when producing hard gelatine capsules, by manipulating the storage 
modulus (G’) and the loss modulus (G’’) of gelatine, hence the gelatine solution being warm when 
the pins are dipped. In very simple terms, the G’ represents the elastic portion of the viscoelastic 
behaviour of a sample, and its related to its solid-state (e.g. when gelatine is hardened). On the 
other hand, G’’ represents the viscous portion of the viscoelastic behaviour and is related to the 
liquid-state of the sample (i.e. when gelatine is softened). 
  
Figure 2.2: In-house produced capsule cap [A] and body [B] pins and support [C] used for the production of the 
depicted gelatine capsules (60%(w/w) gelatine solution in water) [D]. Example of an uncut body [E] and a cut cap 
[F] is shown.  
Rheological measurements of G’ and G’’ vs temperature indicate the temperature at which a 
sample becomes more solid-like (G’>G’’) or more liquid-like (G’’>G’) (Anton Paar GmbH, 2020). 
Thus, during capsule manufacturing, gelatine solutions are warmed to a predetermined 
temperature where G’’>G’, and the gelatine is “liquid” to allow the dipping of the capsule pins. The 
cooling of the solution then causes the inversion of the moduli (G’>G’’), and the gelatine hardens 
forming the capsule shell.  
A very different process occurs when forming polymeric capsule shells. In this process, the polymer 
is dissolved in a solvent, which slowly evaporates to allowing the formation of a film. In this case, 
an adjustment needs to occur in the manufacturing process, with G’ and G’’ no longer playing an 
important role in the hardening process of the shells. The sample solution needs to be fluid enough 
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inverted to dry. Additionally, the thickness of the formed capsules has to be considered as well, as 
this characteristic greatly influences the dissolution of the polymer, and therefore its enteric 
proprieties. The thickness of the final capsule depends on the concentration of the prepared 
solution, with more concentrated polymeric solutions yielding thicker capsules. An interplay 
between polymer concentration and plasticiser type and concentration if thus extremely important. 
In the end, the development of a formulation for the production of enteric capsules has to a provide 
a final solution with appropriate viscosity to allow the dipping of the pins, ensure its adherence 
without dripping and form a capsule with appropriate thickness. Consequently, several 
formulations were prepared and tested (Table 2.2), aiming to achieve optimum conditions.  
2.3.1.1. Optimisation of capsule formulation 
Various polymeric formulations were tested to achieve optimum gastro-resistant capsules from 
each enteric polymer. Table 2.3 summarises the final optimised formulation for each polymer that 
yielded a capsule with appropriate thickness, smoothness and gastroresistance. Lower 
concentrations of polymer and plasticiser yield thinner capsules, which would brake during their 
removal from the pins or during handling. Lower concentrations of plasticiser also caused striations 
to appear along the capsule body during the drying process. Examples of failed capsules are 
shown in Figure 2.3, showing capsule which were too brittle due to low amounts of plasticiser 
(Figure 2.3 A and B) and the effect of the wrong plasticiser on an AS-LF capsule (Figure 2.3 C), 
producing excessive striations, deformations and yellowed capsules.  
 
Figure 2.3: Examples of failed capsules. A – HP-55 capsule (formulation 1.3); B – EUD L100 capsules (formulation 
3.2); C – AS-LF capsule (formulation 2.2),  
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Table 2.3: Composition of optimised capsule formulations for each enteric polymer 





Polymer weight  22.5%a 25%a 27.5%a 27.5%a 
Glycerol  30%b 30%b - - 
Triethyl citrate  - - 40%b 40%b 
Ethanol  80%c 80%c 97%c 97%c 
Water  20%c 20%c 3% 3% 
a: based on total weight, b: based on polymer weight, c: based on solvent weight 
The caps and bodies were cut to appropriate length for “00” size (Podczeck and Jones, 2004), 
their dimensions was measured with a digital micrometre (Table 2.4) and were finally assembled 
into finalised, ready to fill capsules (Figure 2.4). The dimensions of optimised capsule formulations 
were in accordance with the size and tolerances used by commercial suppliers of hard capsules 
(Capsugel, 2013).  
 
Figure 2.4: Capsules obtained from optimised formulations of EUD L100 (A), AS-LF (B), HP-55 (C) and EUD S100 
(D). 
 
Table 2.4: Dimensions (mean ± STD, n=6) for the size “00” size produced from optimised formulations. 
 HP-55 HPMC AS-LF L100 S100 
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2.3.2. Tensile strength  
From the stress vs. strain plots obtained from the tensile tests on the polymeric films (Figure 2.5), 
the elastic moduli were calculated from the obtained slope and are summarised in Table 2.5. The 
measured Young’s moduli of the polymers used in this work are comparable to reported values of 
gelatine used to formulate capsules (De Carvalho and Grosso, 2006; Park, 2009), exhibiting 
resistance to elastic deformation similar to that of standard gelatine hard capsules. It is worth 
noticing a lower yield point for the EUD S100 profile, which is in line with brittleness of the S100 
formulated capsules. Although the yield point was comparatively lower for these capsules (~5 
MPa), it may not adversely affect the mechanical stability of the capsule during packaging, storage 
or transportation. The Young’s modulus for these films also suggests the resistance to elastic 
deformation was comparable to other polymers. Moreover, S100 capsules also met the acid 
challenge test and subsequent drug release in buffer was satisfactory (vide s.3.3.3 for further 
details).  
 
Figure 2.5: Stress vs strain plots of HP-55, EUD L100, AS-LF and EUD S100 polymeric films. The slope of the 
linear region in profiles relates to the Young’s modulus. 
Table 2.5: Young’s modulus of polymeric films used to formulate capsules shells. The values represent average ± 
STD (n=9) 
  Polymer Young’s modulus (MPa)   
  HPMC AS-LF 15.61 ± 2.10   
  HP-55 17.38 ± 0.83   
  EUD L100 13.84 ± 2.98   
  EUD S100 16.66 ± 2.90   
  
Gelatine 
19.5 ± 1.6a; 
15.12 ± 0.05 b 
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2.3.3. Drug release from produced capsules 
Prednisolone release from optimised formulations (Table 2.3) for HPMC AS-LF, HP-55 and 
EUDRAGIT L100 capsules is shown in Figure 2.6A. There was no drug released during the first 2 
hours in acid, confirming the acid resistance of the dosage forms as per pharmacopoeial 
requirements. All capsules rapidly ruptured, exhibiting a drug release within ~5 min on transfer to 
50 mM compendial phosphate buffer pH 6.8. The drug release from enteric capsules was therefore 
comparable to equivalent polymer-coated conventional gastroresistant tablets reported by Liu et 
al., (2011).  
As expected, drug release in physiological bicarbonate buffer was delayed significantly and profiles 
between different polymers were not superimposable. Despite HPMC AS-LF and HP-55 being 
marketed for a dissolution pH threshold above pH 5.5, their release profiles in bicarbonate buffer 
were discriminatory, despite being similar in phosphate buffer. Interestingly, prednisolone release 
from HPMC AS-LF capsules was similar in compendial phosphate and bicarbonate buffers, with a 
lag-time (time until at least 1% of drug is released) in the bicarbonate buffer of around 15 min 
compared with around 5 min in phosphate buffer. However, for HP-55 this lag time was much 
longer in bicarbonate buffer with no drug released until an hour in buffer. EUDRAGIT L100 
exhibited highest lag-time when tested in bicarbonate buffer, with the drug release delayed for 2 
hours after transferring to the buffer phase. The much-delayed release of the drug from enteric 
capsules in physiological bicarbonate buffer was not surprising and also complies with previous 
reports of drug release behaviour from conventional enteric polymer-coated tablets in bicarbonate 
buffer (Liu et al., 2011). This suggests that the behaviour of the enteric polymers is similar when 
used as coatings on conventional tablets or to produce capsule shells. Although longer lag-times 
are observed for enteric capsules (Table 2.6) as compared with coated tablets in Liu et al. (2011), 
these can be attributed to the differences in the thickness of the capsule shells compared with the 
thickness of an enteric coating film applied to a tablet. The thickness of a typical coating on 
gastroresistant tablet is about 50 to 75 microns, with tablet edges usually more thinly coated than 
the faces (Merchant, 2012). Hence, the coating layer around the edges mainly controls the lag-
time in drug release. On the other hand, the produced enteric capsule shells exhibited a uniform 
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thickness ~100 microns (Table 2.4) which is twice more than the classic film coating, contributing 
to the increased lag times. 
Table 2.6: Lag time for the drug release (until 1% release) from polymeric capsules and from conventional polymer-
coated tablets at pH 6.8 (EUD L100, HP-55 and AS-LF) or pH 7.4 (EUD S100), pre-exposed to 0.1M HCl pH 1.2 
for 2h. Data from polymer-coated tablets from Liu et al. (2011) and Ibekwe et al. (2006). 
 Lag times (min) in phosphate buffer Lag times (min) in bicarbonate buffer 



















Coated Tablets  51  151 111 652 351 321 771 1302 
HP-55: Hypromellose phthalate-55; AS-LF: Hypromellose acetate succinate – LF;  
EUD L100: EUDRAGIT L100; EUD S100 = EUDRAGIT S100.  
1: Liu et al. (2011); 2: Ibekwe et al. (2006) 
Nevertheless, the order in which the polymers start dissolving and the capsules start releasing the 
drug is the same as previously reported for coated tablets (Liu et al., 2011), exhibiting a rank order 
of time until drug release of HPMC AS-LF< HP-55< EUD L100. ASLF and HP-55 capsules are 
therefore suitable for gastroresistant applications to target the drug in proximal gastrointestinal 
tract, analogously to already existing capsule-based formulations (e.g. Deltacortil®, Nexium®, 
Voltarol®, Pariet®, etc.). 
The drug release profile from EUD S100 capsules is shown in Figure 2.6B. These capsules were 
subjected to two media changes, the first to pH 6.8 and the second to pH 7.4. As expected, no 
drug release occurred during the acid phase (confirming gastroresistance) and in pH 6.8 (both in 
phosphate and bicarbonate buffers) however the drug was released at pH 7.4 within 15 min in 
phosphate buffer and a much-delayed release in bicarbonate buffer (~4 hours).  
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Figure 2.6: Prednisolone release from enteric capsules in 50 mM compendial phosphate buffer (empty symbols) 
and physiological bicarbonate buffer, mHanks (filled symbols). [A]: HP-55, EUD L100 and AS-LF capsules at pH 
6.8, after 2 h-exposure to 0.1M HCl (not shown); [B]: EUD S100 capsules at pH 7.4 following 2 h in 0.1M HCl and 
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This slower release in bicarbonate buffer is not unexpected and longer lag times in this buffer were 
already reported by Goyanes et al. (2015). Therefore, L100/S100 based capsules are promising 
candidates to target pharmaceutical/nutraceutical agents to the distal gastrointestinal tract, such 
as Asacol®, Octasa®, Salofalk®, pre/probiotics etc. The drug release from these capsules can 
however be improved by further optimising the capsule shell, for instance by using pH responsive 
polymer blends, such as: S100/L100. A dual trigger system (pH and bacteria) comprising two 
independent but complementary release mechanisms can be embedded in capsule shells. This 
fail-safe system has recently shown promising results in the clinic in delivering high dose oral 
mesalazine to inflammatory bowel disease patients (D’Haens et al., 2017). 
Intra- and inter-tablet coating variability in solid dosage forms is a significant factor responsible for 
the huge exhibited pharmacokinetics variability (e.g.  Deltacortil ® (Merchant, 2012)), which is 
further aggravated by other variables such as gastric emptying time (McConnell et al., 2008). The 
capsules produced in this work do not need an additional coating step, and once translated to 
industrial production, the controllable and low variability of capsule wall thickness may reduce in-
vivo variability associated with coating inconsistency in conventional products. Moreover, 
gastrointestinal targeting may be easily achieved by bespoke capsules shells produced at large 
scale where drug release can be tailored by the polymer blend and capsule wall thickness.  
2.4. Conclusion  
Gastroresistant capsule shells were successfully produced, ensuring gastroresistance without the 
need of additional coating. A range of enteric polymers (HPMC derivatives and acrylate-based 
polymers) were used to produce enteric capsule shells to target various regions within the GI tract: 
duodenum – HPMC AS-LF and HP-55 (pH 5.5); jejunum – EUD L100 (pH 6.0); ileocolonic – EUD 
S100 (pH 7.0). The produced capsules were very similar to classic immediate release hard gelatine 
capsules in appearance and resistance to elastic deformation. The technology, if warranted at 
industrial scale, can allow production of capsule shells in bulk, similar to conventional capsules, 
and will enable the industry to produce gastroresistant dosage forms without coating on a 
conventional capsule filling line. This will also be beneficial in early discovery and development in 
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formulating gastroresistant dosage forms for preclinical and clinical trials. This work has already 
been published in a peer-reviewed scientific journal (Barbosa et al., 2019). 
Results showing the differences in drug release in phosphate and bicarbonate buffers have led to 
further exploration of the effect different buffer may exert in polymer dissolution and thus drug 
release. Therefore, the following chapters will focus on the search of a better understanding of how 
drug release from enteric dosage forms is influenced by the surrounding media. This will be studied 
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3.1. Introduction 
In-vivo dissolution of polymeric coatings is a complex interplay between the ionisation constant of 
the polymer and the characteristics of gastrointestinal fluid, such as fluid volume, ionic 
concentration, buffer pKa and capacity. According to the Henderson-Hasselbalch equation, the pKa 
of a weak acid corresponds to the environmental pH at which the concentration of the protonated 
(HA) and unprotonated (A+) forms are equal (vide Figure 1.6). At this pH, the weak acid will be 
partially ionised; whereas almost a full ionisation is expected when the environmental pH is 2 units 
above its pKa (Figure 1.6). 
The enteric polymers employed as gastro-resistant coatings behave as weak acids in solution and 
exhibit a pH-dependant ionisation. At a pH above the polymer’s pKa value, the carboxylic acid 
groups tend to ionise, increasing [A-] and proportionally decreasing [HA] which will increase 
polymer’s solubility, leading to complete dissolution (Figure 1.6). This ionisation produces a 
proportional increase in negatively charged groups on the surface of the dissolving polymer 
yielding a net negatively charged surface. The charged surface acts thus as a solid particle, with 
a surface potential, affecting the ions in the surrounding media. This behaviour at this solid-liquid 
interface can be compared to a zeta potential as it represents the electrical potential at the shear 
plane, which separates a stationary layer and a mobile layer of charges (Figure 3.1).  
 
Figure 3.1: A schematic showing the potential difference as a function of distance from the charged surface of a 
particle in a medium (Malvern Instruments Ltd, 2005). 
Zeta potential is an indirect measurement of the charge present at the slipping plane (Figure 3.1), 
obtained by electrophoretic light scattering (ELS). This technique measures the electrophoretic 
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mobility of a particle or molecule in a solution or dispersion, i.e. when an electric field is applied, 
particles will move in accordance with its charge, towards the positive or negative electrode. This 
mobility is tracked by monitoring the light scattered by the particles and is then converted to a 
correspondent zeta potential value. Mobility of charged particles will depend not only on the particle 
zeta potential value, but also on its size, on the ionic strength of the media and the chemistry and 
molecular weight of the specie being measured.   
In the case of gastroresistant polymers, the increase of the pH of the medium will result in an 
augmented ionisation of the acidic groups, which leads to a proportional accumulation of protons  
and an increase in the charge at the polymer’s surface. This in turn should be measurable as an 
increment in the zeta potential. The maximum absolute value of the zeta potential (Zetamax) 
therefore corresponds to the maximum ionisation of the polymer, i.e. when [A-] is maximal. Hence, 
an equal concentration of the weak acid to the concentration of its conjugated base ([A-] = [HA]) 
can be attributed to the median between the Zetamin and the Zetamax, and the corresponding pH of 
the medium will correspond to the pKa value of the polymer. 
An early work by Burke and Barrett (2003), described the use of zeta potential to determine the 
apparent pKa value of multi-layered thin films assembled in colloidal silica. Later, a new method 
was developed to calculate the pKa of multi-layered thin films based on the surface tension 
measurements on the surface-to-air interface (Dickhaus and Priefer, 2016). As the authors 
describe a number of techniques have been reported to determine the pKa of acids (e.g. 
potentiometric, UV-Vis spectrometry, HPLC, conductometry, polarimetry, computational, among 
others), yet mentioning they will not all be suitable to all kinds of acids, such as long chain acidic 
polymers. 
The hypothesis in this work was to show that zeta potential measurements may be used as a 
simple and economical technique to study the ionisation behaviour of gastroresistant polymers and 
determine their pKa value. The technique would be performed under different conditions, mimicking 
the pH changes across the GI tract, allowing the study of the ionisation behaviour of different 
polymers for a range of pharmaceutical applications, aiding in a more rational formulation 
development for gastroresistant dosage forms.  
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3.2. Materials and methods 
3.2.1. Materials 
Hydrochloric acid NIST 1M and sodium hydroxide NIST 1M solutions were purchased from Fisher 
Scientific (Leicestershire, UK). EUDRAGIT® and HPMC AS/P polymers used in this work were 
kindly provided as samples from Evonik Industries AG, Germany and from Shin-Etsu, Japan, 
respectively. Their proprieties are summarized in (Table 3.1).  
Table 3.1: Synthetic polymers used in this study, respective characteristics and structures. 

















E100 [A] £5.0 20.8 - 25.5 47.000 
  
Methacrylic 
acid 2  
L100 [B] ³6.0 46.0 - 50.6 125.000 










LF [C] ³5.5 14.0 – 18.0 18.000 





  Phthalyl 4  
HP-50 [D] ³5.0 21.0 – 27.0 78.000 
HP-55 [D] ³5.5 27.0 – 35.0 84.000 
  
  
A: x – dimethylaminoethyl methacrylate, y – butylmethacrylate, z – methyl methacrylate (ratio x : y : z -   2:1:1);  
B: x – Methacrylic acid, y – Methyl Methacrylate (ratio x:y : L100 - 1:1 / S100 – 1:2); 
C: Succinoyl groups; D: Phthalyl group. 
1: Evonik Industries AG, (2015); 2: Evonik Industries AG, (2012); 3: Shin-Etsu Chemical Co., (2018); 4: Shin-Etsu Chemical Co., (2002) 
[A] [B] 
[C] [D] 
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Tara and Konjac gums were acquired from Ingredients UK Limited (Hampshire, UK). Sodium 
alginate (180947), gum arabic (G9752), κ-carrageenan (22048), chitosan (75-85% deacetylation, 
448877), guar gum (G4129), and high-methoxyl citrus peel pectin (P9135) were purchased from 
Sigma-Aldrich (Dorset, UK). Locust bean gum (GC1233) was purchased from Glentham Life 
Sciences (Wiltshire, UK). Psyllium husk powder was acquired from Bulk Powders® (Sports 
Supplements Ltd, Colchester, UK). Supplier product codes for the natural gums are given in 
brackets.  
Arabinoxylan was provided by a colleague from the research group. Arabinoxylan was obtained 
from psyllium husk powder via an alkaline hydrolysis followed by ultrafiltration (Campbell et al., 
2019).  
3.2.2. Method validation for pKa determinations 
To determine the pKa value of different polymers, the zeta potential of polymeric dispersions at 
different pH was measured and their ionisation behaviour was assessed. For this, the preparation 
of the dispersions had to be tested and optimised, such as the measurement parameters and the 
method for the calculation of the pKa. The work was divided in two stages, with the first being the 
validation of the method. In this phase, the tested polymers were commercially available polymers 
used as coatings in gastro-resistant dosage forms (Table 3.1). The use of these well-known 
polymers with their detailed characteristics (dissolution pH threshold, type of ionisable groups and 
their quantity) allowed for a more robust and controlled validation of the technique.  
3.2.2.1. Optimisation of polymeric dispersions 
The first stage of the method development was the optimisation of the polymeric dispersions to be 
measured by ELS to determine the zeta potential of the tested polymers. It is essential with ELS 
to have a properly prepared dispersion, not only due to large agglomerates interfering with the light 
scattering, but more importantly due to the need to have enough dispersed particles that may be 
detected by the laser during the ELS measurements. Agglomerated particles will interfere with the 
measurement, however if the number of well-dispersed particles greatly overcomes the 
agglomerates, the quality and reproducibility of the measurement is assured. Hence, the main goal 
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of this stage was to achieve maximum efficiency in producing a good dispersion with low size 
particles.  
Since the zeta potential measurements were performed at a range of pH from 2-12, the starting 
media could be a solution at pH 2 or at pH 12, which would be titrated in the appropriate direction. 
When a gastro-resistant dosage form is administered, the pH it withstands will be acidic in the 
stomach and will gradually increase as the stomach empties its content to the intestine and travels 
further down the GI tract. Therefore, the acidic pH was chosen as a starting point in order to 
resemble the pH variations in the GI tract.  
Three sets of dispersions for each polymer were prepared at 0.5% (w/v) in 0.1M HCl, with the first 
being stirred on a magnetic stirring plate for 10 min at 1.000 rpm, the second homogenised for 10 
min in a high-shear mixer (Silverson L5M mixer) at 5.000 rpm and the third on a magnetic stirring 
plate for 5 min at 1.000 rpm, followed by 5 min in the high-shear mixer at 5.000 rpm. The polymers 
used and their characteristics are summarised in Table 3.1. Next, the particle size of these mixtures 
was measured by dynamic light scattering (DLS), using a Malvern Zetasizer Nano ZS (Malvern 
Panalytical Ltd., Royston, UK). 
After the optimisation, dispersions were prepared at different concentrations (0.1-0.5% (w/v)) to 
test possible concentration effects in the zeta potential.  
3.2.2.2. Optimization of zeta potential measurements 
The second stage involved zeta potential measurements, which were performed using a Malvern 
Zetasizer Nano ZS (Malvern Panalytical Ltd., Royston, UK) coupled to an MPT2 automatic titration 
unit. This experimental setup allows the auto-titration and recirculation of sample in an enclosed 
system with robust and reproducible measurements. The software allows for multiple choices to 
be made, especially regarding the type of titrant used (acid or base), the concentration of the titrant, 
the intervals of pH to be titrated and the tolerance of obtained pH for each titration step. The type 
of titrant used was NaOH, however the concentration, the pH increments and the pH tolerance had 
to be optimised. Concentrations of titrants of 0.05, 0.1 and 1M NaOH were tested. The increments 
tested were 0.1, 0.2, 0.3 and 0.5 units of pH with tolerances of 0.02, 0.05, 0.1 and 0.15. Sample 
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runs acquired data in triplicate for each pH value and each polymer concentration was tested in 
triplicate.  
After the measurement conditions were optimised, the titrations were also performed in the inverse 
direction (i.e. from pH 12 to 2) with 1M HCl. The reverse titration would show any potential effect 
of dissolved and dispersed states of the polymer on zeta potential measurements and in pKa values 
estimations. The MPT-2 contains a pH probe which was accurately calibrated daily at controlled 
room temperatures and the calibration data compared to previous measurements to assure 
reproducibility of the obtained data.  
3.2.2.3. Optimization of calculations 
The pKa value of the tested polymers was estimated based on the obtained zeta potential vs pH 
curves. The methodology for calculating the pKa value evolved over the course of the work and as 
more data was being generated. For each sample, data in triplicate was averaged and a zeta 
potential vs pH curve was obtained, from which a minimum (Zetamin) and maximum (Zetamax) zeta 
potential plateaus were defined. The early method of calculation involved extrapolating the pH 
value corresponding to half of the Zetamax. As this method proven to not be accurate, a new 
approach followed which considered both Zetamin and Zetamax into calculations. This approach 
considered the median value between Zetamin and Zetamax and from there the pH value which would 
correspond to the pKa was found. Ultimately, the final method for calculation involved the 
determination of the median zeta value. This value was then be used to find the corresponding pH 
value using a linear regression of the zeta potential vs pH curve, fitted between the Zetamin and 
Zetamax plateaus (Figure 3.2).  
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Figure 3.2: Example of analysis applied to each zeta potential vs. pH curve, with the determination of the Zetamin, 
Zetamax and median zeta potential, applied to the linear regression to determine the corresponding pH, i.e. pKa. 
3.2.2.4. Zeta potential measurements and pKa determination at different concentrations 
Considering the methodology used for the zeta potential determination (DLS), the effect of the 
concentration of the polymeric dispersions needed to be assessed to validate the robustness of 
the technique over a range of concentrations. Therefore, suspensions with different polymer 
concentrations (from 0.1-0.5% w/v) were prepared as optimised in section 3.2.2.1 and the zeta 
potential was measured. To assess the possible significance of polymer concentration influence, 
a statistical analysis was performed on the determined pKa values using One-way ANOVA tests, 
with a significance level of 0.05. Differences were considered non-significant when p>0.05. 
3.2.3. Ionization studies and pKa determination of natural materials 
Following the optimisation and validation of the methodology using commercially available 
synthetic polymers, diverse natural materials with well-known uses in food and pharmaceutical 
applications were tested. The ionisation behaviour of these polymers was investigated and, where 
applicable, their pKa value was estimated. Considering the nature of these materials and previous 
experience handling natural polymers, these samples were titrated only over a pH range of 2 to 10 




























Table 3.2: Natural materials used in this study and their food and pharmaceutical applications.  
Gum Structure Common uses and applications 
1. Gums containing acidic moieties  
Gum Arabic 
Main chain consisting of β-(1,3) linked galactose units with 
branches of β-(1,6) linked galactose and arabinose with terminal 
rhamnose and glucuronic acid. Contains 2% of protein within the 
structure 1. 
Suspending agent, emulsifying agent, binder in tablets, demulcent 
and emollient in cosmetics 2,3, osmotic drug delivery 4. 
Citrus peel 
pectin 
Linear chain of α-(1,4) linked galacturonic acid units, with up to 80% 
of these occurring as methyl esters. Contains up to 4% of rhamnose 
units, which are then linked to arabinose, galactose and xylose side 
chains 1. 
Thickening agent, suspending agent, stabilizer 2, 5, floating beads 6, 
controlled drug delivery (ocular 7, transdermal 8, colonic 9, 10) 
Alginate 
Linear structure consisting of (1,4) linked β-mannuronic and α-
guluronic acids, with proportions depending on the source 1.  
Thickening agent, stabilizer 2, 5, sustained release agent 11, 12, film 
coatings 13, mucoadhesive systems 14. 
Arabinoxylan 
Main chain consisting of β-(1,4) xylose, substituted with arabinose 
on the C-2 and/or C-3 positions 15 and phenolic acids (e.g. ferulic 
acid) linked to C-5 position of arabinose 16. 
Wound dressing 17, gelling agent 18, controlled drug delivery 
systems 19 
2. Gums containing basic moieties 
Chitosan 
Deacetylated derivative of chitin composed of randomly distributed 
β-(1-4)-linked glucosamine (deacetylated unit) and N-acetyl-
glucosamine (acetylated unit) 14. 
Tissue engineering 20, 21, 22, 23, 24, 25, 26, wound dressing 27, 28, 
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Table 3.2: Natural materials used in this study and their food and pharmaceutical applications. 
Gum Structure Common uses and applications 
3. Sulphated gums 
κ-carrageenan 
Disaccharide repeat unit of β-(1,3) linked galactose-4-sulfate and α-
(1,4) linked 3,6-anhydrogalactose residues 1. 
Thickening agent, gelling agent, stabilizer 2, laxative 5, tablet 
matrix 31, controlled release agent 32, 33, 34. 
4. Gluco and galactomannans 
Guar gum 
Main chain consisting of β-(1,4) mannose units with galactose with 
α-(1,6) linked branches. Mannose to galactose ratio is 2:1 1. 
Binder, disintegrant, thickening agent, emulsifier, laxative 2,5, 
sustained release agent 35, colon targeted drug delivery 36.  
Tara gum 
Main chain consisting of β-(1,4) mannose units with galactose with 
α-(1,6) linked branches. Mannose to galactose ratio is 3:1 1. 
Thickener, stabilizer 2,5, controlled release agent 37, 38, 39. 
Locust bean 
gum 
Main chain consisting of β-(1,4) mannose units with galactose with 
α-(1,6) linked branches. Mannose to galactose ratio is 4-4.5:1 1. 
Thickener, stabilizer 2,5 and controlled release agent (oral, buccal, 
colonic, ocular and topical) 40.  
Konjac 
Main chain consisting of β-(1,4) mannose and glucose units with α-
(1,3) linked branches. Mannose to glucose ratio is 1.6:1 1.  
Gelling agent, thickener, emulsifier, stabilizer5 Controlled release 
formulation 41, 42, 43, 44. 
1: (Williams and Phillips, 2003a), 2: (Williams and Phillips, 2003b), 3: (Beneke et al., 2009), 4: (Lu et al., 2003), 5: (Prajapati et al., 2013) 6: (Sriamornsak et al., 2007), 7: (Giunchedi et al., 1999), 8: 
(Musabayane et al., 2003), 9: (Vandamme et al., 2002), 10: (Wong et al., 2011), 11: (Hodsdon et al., 1995), 12: (Maiti et al., 2009), 13: (Rajsharad et al., 2005), 14: (Kesavan et al., 2010), 15: (Dornez 
et al., 2009), 16: (Mendis and Simsek, 2014) 17: (Aduba et al., 2019), 18: (Niño-Medina et al., 2010) 19: (Tulain et al., 2018), 20: (Kawakami et al., 1992), 21: (Mattioli-Belmonte et al., 1999), 22: (Tze 
Wen Chung et al., 2002), 23: (Taek Woong Chung et al., 2002), 24: (Hu et al., 2004), 25: (Wang et al., 2005), 26: (Shalumon et al., 2009), 27: (Kumar et al., 2010), 28: (Madhumathi et al., 2010), 29: 
(Rahman Bhuiyan et al., 2017), 30: (Ali and Ahmed, 2018), 31: (Picker, 1999), 32: (Leong et al., 2011), 33: (Li et al., 2014), 34: (Mahdavinia et al., 2015), 35: (Al-Saidan et al., 2005), 36: (Chourasia 
and Jain, 2004), 37: (Zeng et al., 2005), 38: (Rutz et al., 2013), 39: (Ma et al., 2017), 40: (Dionísio and Grenha, 2012), 41: (Du et al., 2006), 42: (Alvarez-Manceñido et al., 2008), 43: (Fan et al., 2008), 
44: (Wang et al., 2014) . 
C
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3.3. Results 
3.3.1. Method validation for pKa determination 
For the validation of the proposed method, the acrylic and HPMC-based polymers were used. Their 
ionisation behaviour was obtained over a range of pH and their pKa was calculated. The 
optimisation of the technique and of the calculation parameters are described in the following 
sections.   
3.3.1.1. Optimization of polymeric dispersions  
For the optimization of the polymeric dispersions used in the zeta potential measurements three 
methods were tested involving a magnetic stirring plate, a high shear mixer or a combination of 
both.  
Results showed that using the magnetic stirring plate alone was not enough to break the 
agglomerates formed during the mixing at low pH, not forming a suitable dispersion to be measured 
by ELS. The use of the high-shear mixer alone was also not optimal, as without the wetting of the 
particles induced by the magnetic stirring, these would adsorb to the metallic end of the mixer, 
dampening the homogenisation. 
From Figure 3.3 is possible to observe that with the addition of the homogenisation step, particle 
size in all dispersions decreased extensively. AS-LF and AS-HF showed a less pronounced 
reduction, however this is due to the already low particle size achieved by simple stirring. These 
polymers are supplied as much finer powders than the remaining polymers, thus showing much 
lower values of particle size. The combination of magnetic stirring followed by high-shear mixing 
was therefore chosen to continue the preparation of the following polymeric dispersion for zeta 
potential measurements.  
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Figure 3.3: Particle size (dynamic light scattering) measurements of the prepared dispersions using the magnetic 
stirrer alone, or a combination of magnetic stirring + high-shear mixer. 
3.3.1.2. Optimisation of measurement parameters 
The choice of the pH increments and tolerance was based on the reproducibility of the results, 
time of run per sample and actual conclusion of the measurements.  
Increments in pH of 0.1 or 0.2 units would lead to long run times per sample, reaching 7 h for 0.1 
units and about 4 h for 0.2 units. Also, small increments in pH would require smaller tolerances, 
causing the algorithm of the software to not accept the obtained pH more often after titrations, and 
continuing to titrate for longer times until acceptance was achieved. This would lead to much longer 
run times, with runs sometimes not being concluded due to excessive time used in titrating the 
sample. On the other hand, increments of 0.5 units would lead to less data points in the titration 
curves, providing less accurate results for further calculation of the pKa value.  
As already mentioned, tolerances of 0.02 and 0.05 would cause severe delays to the titrations and 
increase the sample run time. However, the need for a higher tolerance arose not only from the 
long run times when using smaller tolerances, but also due to the reproducibility of the 
measurements. When the tolerance was low (0.02 or 0.05) and the software’s algorithm would not 
accept the obtained pH after a titration, more volume of titrant was added until acceptance. 
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common that the pH would increase too much at certain pH points when lower tolerances were 
used, due to over-addition of titrant. This would provide zeta potential vs. pH curves with missing 
values near the pKa and non-matching replicates, decreasing the accuracy of the calculations, and 
providing over or underestimated pKa values. In the end, the combination of titration parameters 
which provided the smoothest, less time-consuming titrations and less prone to errors consisted 
in increments of 0.3 units with a tolerance of 0.15 units.  
3.3.1.3. Optimisation of pKa determination 
For the calculation of the pKa value, different analyses were applied to the generated data. As 
stated before, the pKa value corresponds to the pH at which an ionisable molecule contains 50% 
of its groups ionised. Following this, the first method to calculate the pKa consisted in simply halving 
value of Zetamax which would correspond to 50% ionisation and use it to extrapolate the 
corresponding pH. However, this approach was very keen to errors as it did not account for the 
Zetamin values, causing over- or underestimations of the pKa when the Zetamin was not zero.  
Improving from the incomplete methodology, the second approach accounted for both Zetamin and 
Zetamax, using both to determine the median Zeta potential, necessary to extrapolate the 
corresponding pH. This allowed for a more accurate determination of the true zeta potential 
variation caused by the shifting pH, leading to more reproducible results.  
Aiming for a more automated method, slight alterations were made. Both Zetamin and Zetamax were 
calculated from the average of each plateau, with the median Zeta determined using these 
averages, and a linear regression was fitted to the linear portion of the zeta potential vs. pH curve 
to extrapolate the corresponding pKa value (Figure 3.2). 
This final approach allowed calculations with minimised errors and was applied for the optimisation 
of the previously described parameters of the measurement (pH interval and tolerance), allowing 
to exclude sub-optimal measurement parameters.  
3.3.2. Zeta potential measurements of synthetic polymers  
The zeta potential measurements of the tested synthetic polymers are summarised in Table 3.3, 
where a clear trend between zeta potential and environmental pH can be seen with all 
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measurements showing an increase in the zeta potential with an increase in the environmental pH. 
This is not surprising for weakly acidic polymers. The opposite trend was observed for EUDRAGIT 
E100 (a weak base), with zeta potential decreasing with increasing pH, showing that this polymer 
is more extensively ionised at lower pHs, i.e., pH<pKa. 
The weakly acidic polymers exhibited a near zero zeta potential at low acidic pH (pH ≈ 2), 
suggesting most of the polymeric species were at their unionised state (>99%) (Figure 1.6). As the 
pH increases, there is an increase in the ionised fraction (i.e., [HA] to [A-]) which results in a net 
increase in negative charge on the polymer surface causing an increase in the zeta potential, which 
plateaus when most of the HA has been converted to A-. Interestingly, the shape of the zeta-
profiles was independent of polymer concentrations used (Figure 3.4), hence increasing the 
reliability of measured pKa values using this technique. 
The Zetamax was determined from zeta profiles and the pKa value of each polymer was estimated 
accordingly. Table 3.3 summarises the estimated pKa values using this technique in comparison 
with the reported literature values. 
3.3.2.1. Effect of polymer concentration  
It can be argued that a change in polymer concentration may influence the Zetamax and therefore 
can affect the pKa value estimation. Therefore, the effect of polymer concentrations on pKa value 
estimation was also studied to ascertain the reliability of the measurement. Interestingly, the 
concentration of the polymeric dispersion does not affect the pKa value estimation (Figure 3.5), 
with statistical analysis exhibiting no significant differences (p>0.05) in the estimated pKa values  
between different concentrations.. In the case of HP-50, however, the estimated pKa value 
appeared to decrease with increasing polymer concentration from 0.1 to 0.5% w/v. To confirm this 
behaviour, a higher concentration of 1% w/v was tested, and no significant difference was found 
(p >0.05) in estimated pKa values across concentrations. 
Figure 1.6 indicates that at an environmental pH two units above the polymer’s pKa value extensive 
ionisation occurs, which leads to complete dissolution of polymeric chains. However, this may not 
be the case with every polymer, and whilst some may dissolve enough to enable drug release at 
earlier stages of ionisation, others may only allow the release of the drug at much later stages. 
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Table 3.3: Summary of estimated and reported pKa values for the commonly used synthetic polymers. 
Polymer Dissolution pH threshold Zetamax Estimated pKa Reported pKa * 
Synthetic polymers    
EUDRAGIT E100 £ 5.0 1 24.88 ± 1.66 8.45 ± 0.14 9.0 4 
HP-50 ³ 5.0 2 -14.69 ± 0.89 3.99 ± 0.09 4.20 5 
HP-55 ³ 5.5 2  -19.75 ± 0.95 3.54 ± 0.20 4.49 
5 
4.83 ± 0.04 6 
HPMC AS-LF ³ 5.5 3  -15.25 ± 1.14 4.80 ± 0.20 
5.10 ± 0.07 7 
5.09 ± 0.05 6 
EUDRAGIT L100 ³ 6.0 1 -29.88 ± 1.80 4.45 ± 0.13 6.62 ± 0.04 
7 
6.45 ± 0.03 6 
HPMC AS-HF ³ 6.8 3 -8.76 ± 0.29 4.85 ± 0.16 4.82 ± 0.03 
7 
5.15 ± 0.05 6 
EUDRAGIT S100 ³ 7.0 1 -27.61 ± 0.59 4.91 ± 0.13 6.76 ± 0,03 
7 
6.66 ± 0.05 6 
Natural polymers    
Gum Arabic  -12.13 ± 0.13 3.20 ± 0.11 3.18 ± 0.02 7, # 
Citrus pectin  -16.05 ± 0.57 3.37 ± 0.04 3.5 8 
Alginate  -29.94 ± 1.45 3.45 ± 0.03 3.4 9; 4.4 10 
Chitosan  28.79 ± 1.11 6.75 ± 0.22 
6.32 ± 0.02 -  
6.47 ± 0.03 11 
Arabinoxylan  -19.26 ± 1.08 4.61 ± 0.19 - 
*: potentiometric determinations from literature. 
#: based on glucuronic acid pKa value in gum Arabic 
1: Evonik Industries AG (2019), 2: Shin-Etsu Chemical Co. (2002), 3: Shin-Etsu Chemical Co. (2018), 4: Quinteros et al., (2011), 
5: Davis et al., (1986), 6: Riedel and Leopold (2005), 7: Schmidt-Mende (2001). 
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Figure 3.4: Zeta potential vs. pH profiles of various synthetic polymers at concentrations from 0.1 - 0.5 % (w/v) 
showing no significant effect of changes in concentration on zeta-profiles and pKa value estimation. 




Figure 3.5: Effect of polymer concentration (0.1% - 0.5%w/v) on pKa value estimation. Closed symbols (●) represent 
the estimated pKa values corresponding to polymer concentation. The open symbol (○) on HP-50 graph represents 
an additional measurement at 1%w/v polymer concentration to confirm a possible trend. No significant difference 
was found between concentrations (p>0.05) for all tested polymers. 
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3.3.2.2. Hydrophobic effects on zeta potential measurements  
Certain polymers (e.g. EUDRAGIT L100 and S100) demonstrate a slightly positive zeta potential 
at lower pHs (pH 2 to 4) (Figure 3.4), particularly at the lowest concentration studied (0.1% w/v). 
However, this effect disappears at polymer concentrations ≥ 0.3%w/v. This may be attributed to 
the non-ionised state of these polymers at low concentrations under acidic conditions. At low pH 
(pH<<pKa), the acidic moieties of the polymeric chains are unionised and undissolved, which 
increases the polymer’s hydrophobicity compared to when some charged species are present,  
causing the polymer structure to fold so to reduce the exposed surface area of the chains. 
Hydronium ions (H3O+) behave more hydrophobically than water molecules, accumulating at the 
interface between water and a hydrophobic media (Luxbacher, 2014; Vácha et al., 2008). 
Therefore, at acidic pH, the adsorption of H3O+ ions to the uncharged polymeric chains creates a 
slightly positive charged surface at very low polymer concentrations as seen in Figure 3.4. On 
increasing pH, the ionisation of the acidic groups produces a substantially more negatively charged 
surface and hence an overall negative zeta potential. This effect was absent at higher polymer 
concentrations (≥ 0.3%) possibly due to the increased polymer/hydronium ion ratio. The polymeric 
chains are therefore less densely covered by the positively charged H3O+ ions. This renders 
negligible movement of the particles during measurements when a charge was applied during 
electrophoretic light scattering and generated a signal near zero mV. 
3.3.2.3. pH dissolution threshold vs. pKa 
Figure 3.6 compares the estimated pKa value of polymers to their reported dissolution pH 
thresholds. For all enteric polymers, it was found that the reported dissolution pH thresholds were 
always above the estimated pKa value. In contrast, EUDRAGIT E100, a reverse enteric polymer, 
contains ionisable amine groups. Therefore, complete ionisation (i.e., dissolution) of the polymer 
is expected below its measured pKa value. As mentioned earlier, the manufacturers do not mention 
how the dissolution pH thresholds were calculated and there is no known standardisation of 
approach among different polymer manufacturers. It is likely, that some may report complete 
dissolution of a polymeric film at a given pH while others may rely upon the onset of drug release 
from the enteric coated a dosage form. In our study, the rank order of polymer dissolution pH-
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thresholds did not follow the measured pKa value for some polymers. For instance, the estimated 
pKa value for HP-50 was higher than for HP-55 despite its lower dissolution pH threshold. This can 
be attributed to the polymer structure and the density of acidic (ionisable) moieties on polymer 
backbone (Table 3.4).   
It can be seen from the zeta potential measurements (Figure 3.4) that EUDRAGIT L100, HPMC 
AS-LF and HP-55 have higher Zetamax values compared to their counterparts, EUDRAGIT S100, 
HPMC AS-HF and HP-50, respectively. This is in agreement with density of acidic ionisable groups 
on the polymer (Table 3.4).  
 
Figure 3.6: Dissolution behaviour of the tested polymers. The bars represent dissolution pH-thresholds (i.e., shaded 
areas represent the pH at which the polymers are undissolved). The open circles (○) represent the estimated pKa 




























Chapter 3    Zeta potential: the first cues to understand polymer ionisation 
66 
Table 3.4: Composition of the respective free carboxyl groups of the studied polymers and respective structures. 
Polymers % ionsable groups pH Dissolution Threshold Zetamax (mV) 
HP-50  21-27% (phthalyl) 1 5.0 -14.69 ± 0.89 
HP-55  27-35% (phthalyl) 1 5.5 -19.75 ± 0.95 
HPMC AS-LF  14-18% (succinoyl) 2 5.5 -15.41 ± 1.22 
HPMC AS-HF 4-8% (succinoyl) 2 6.8 -8.76 ± 0.29 
EUDRAGIT L100  46-50% (methacrylic) 3 6.0 -29.88 ± 1.80 




A: Phthalyl group; B: Succinoyl groups; C: x – Methacrylic acid, y – Methyl Methacrylate. 
1: (Shin-Etsu Chemical Co., 2002), 2: (Shin-Etsu Chemical Co., 2018), 3: (Evonik Industries, 2012) 
A lower pH dissolution threshold is reported by the manufacturers for polymers containing 
succinoyl (HPMC AS) or methacrylic groups (EUDRAGIT S100/L100) if higher number of acidic 
moieties are present on the polymer backbone (Table 3.4). For these polymers, increased density 
of ionisable species achieves the degree of ionisation needed to show significant dissolution at a 
lower pH than a polymer with lower density of ionisable species. The latter would need a higher 
pH to attain the degree of ionisation needed for the dissolution of the polymeric strands. However, 
this is not true for the polymers containing a phthalyl group (HP 50/55). In this case, the polymer 
with higher number of acidic functional groups (HP-55) exhibited the highest dissolution pH 
threshold. This may be due to the presence of an aromatic acidic moiety that hinders the dissolution 
of the polymeric chains when compared to an aliphatic substituent group (such as HPMC AS) 
(Figure 3.7). The process of dissolution of a polymer involves water diffusion into the polymer 
matrix, which eventually leads to the disentanglement of the polymeric chains and consequent 
dissolution (Figure 3.1D). For these polymers, the presence of the aromatic group may influence 
its solubility by two factors.  
[A] [B] [C] 
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Firstly, the aromatic ring creates a more planar spatial conformation (Figure 3.7E). Due to a higher 
number of sidechains on the HP-55 polymer backbone (and thus a higher number of aromatic 
rings), increased interaction between polymeric chains (p-p interactions and hydrophobic 
interactions within the aromatic rings) may occur. This may mean more complex entanglement of 
the polymeric chains, and possibly a slower dissolution. This would explain why the estimated pKa 
value for HP-50 is higher than the one for HP-55 (3.94 vs. 3.54), even though its dissolution pH 
threshold is lower. Secondly, the phthalyl group has less conformational flexibility compared to the 
succinoyl group, as it only contains two rotatable bonds and both are on the same side of the 
aromatic ring (Figure 3.7F) whereas all the carbons in the succinoyl group can freely rotate (Figure 
3.7C) .This causes an increased rigidity in phthalyl groups compared to the succinoyl group leading 
to less freedom of movement during the disentanglement of the polymeric chains (Figure 1.7). 
Ultimately, this effect hampers polymer dissolution, despite the ionisation of acidic moieties across 
polymer chains. Therefore, for these polymers, the presence of aromatic rings possibly plays a 
more important role in polymer dissolution than its ionisation. 
 
Figure 3.7: 3D structures of succinoyl (A, B and C) and phthalyl (D, E and F) groups. Atoms in green represent 
rotational bonds. Atoms in yellow represent the binding site to the remaining polymer structure. Figure drawn using 
information from Shin-Etsu Chemical Co. (2018, 2002). 
3.3.2.4. pKa estimation: Zeta potential vs potentiometric determinations 
In this work, the pKa value of various polymers was measured based on their ionisation behaviour 
obtained from the zeta potential profiles. The proposed method may present more accurate pKa 
estimations than the traditional potentiometric determination, which are based on measuring bulk 
solution pH (the concentration of H+). However, it is evidenced that the pH at the boundary layer 
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(the interface between the polymeric coatings and the media, Figure 1.7) may greatly differ from 
the bulk pH (Harianawala et al., 2002; Krieg et al., 2014) and therefore can significantly influence 
the ionisation and dissolution of these polymers. The boundary layer has an abundance of H+ being 
released from the dissolving polymer which do not diffuse into the bulk solution readily, rendering 
it more acidic than the bulk solution. Potentiometric determinations therefore rely on bulk pH of the 
media and do not consider conditions within the boundary layer. This leads to an underestimation 
of the titrant needed to raise the bulk pH thus shifting the titration curve to slightly higher pH values 
leading to over estimation of pKa values. Hence, the effective pKa values of these polymers are 
expected to be lower than the apparent potentiometric determinations. 
In contrast, studies involving zeta profiles rely on zeta potential (i.e., charge) determinations using 
dynamic light scattering. These measurements relate to the net charge acquired by the dissolving 
polymer at the boundary layer instead of relying merely on bulk pH determinations. This leads to 
lower pKa values estimations than those reported by potentiometric methods (Table 3.3) and 
therefore a more accurate representation of ionisation behaviour of these polymeric materials at 
the boundary layer.  
3.3.3. Ionisation and pKa determination of natural polymers 
After satisfactory method development and determinations using well-known synthetic polymers, 
the described method was employed to study the ionisation behaviour of some commonly used 
natural gums (polysaccharides) over a range of pH values. The studied polysaccharides differ 
significantly in their chemical structures and distinctive ionisation behaviour was found from their 
zeta profiles. 
3.3.3.1. Gums containing acidic moieties 
This group represented gums containing sugar acids. They comprise sugar monomers where 
terminal hydroxyl groups are oxidised to carboxylic acids forming uronic acids. The presence of 
these ionisable groups may therefore play an important role in the polysaccharide dissolution. 
From this group of polysaccharides, gum arabic, citrus pectin, sodium alginate and arabinoxylan 
were studied and their ionisation behaviour is shown in Figure 3.8 and estimated pKa values are 
summarised in Table 3.3. 
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The shape of the zeta profiles corresponds to typical weak acid ionisation behaviour as found with 
gastro-resistant polymers, which can be attributed to the presence of uronic acids moieties in the 
polymeric structure or phenolic acid residues in the case of arabinoxylan. Alginate has a much 
higher Zetamax than gum Arabic and citrus pectin, arising from differences in their polymeric 
structure. Gum Arabic possesses a chain of galactose units containing acidic units only at the 
terminus of each branch (Table 3.2). Citrus pectin contains a long chain of galacturonic acid units; 
however, 80% of these are in the form of methyl esters, hence reducing the number of available 
ionisable groups. Alginate, on the other hand, has a linear structure comprising repeating units of 
mannuronic and guluronic acids. This explains a higher Zetamax found in alginate compared to 
pectin and gum arabic. Arabinoxylan, on the other hand, has its ionization behaviour dictated not 
by uronic acid residues, but by the phenolic acids in its structure, such as ferulic acid. Interestingly, 
arabinoxylan, HP-50 and HP-55, which bear similar functional groups (aromatic acids) have 
displayed similar zetamax (~20mV), which further demonstrated the influence of the present 
functional groups.  
The ionisation behaviour of these polymers was similar to those employed in a typical gastro-
resistant formulation. Therefore, these polymers have been extensively investigated to formulate 
modified release delivery systems (Albertini et al., 2010; Alvarez-Lorenzo et al., 2013; Arroyo-
Maya and McClements, 2015; Bagheri et al., 2014; Chen and Subirade, 2009; Chuang et al., 2017; 
Czarnocka and Alhnan, 2015; De Barros et al., 2015; Kesavan et al., 2010; Lambert et al., 2008; 
Lu et al., 2003; Luo et al., 2015; Maiti et al., 2009; Reis et al., 2006; Sansone et al., 2011; Shi et 
al., 2016, 2013; Sriamornsak et al., 2007; Vandamme et al., 2002; Villena et al., 2015; Wang et 
al., 2014; Wong et al., 2011; Wu et al., 2016; Zhang et al., 2014). 
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Figure 3.8: Zeta potential vs. pH profiles of polysaccharides containing acidic (alginate (0.05% (w/v)), Citrus pectin 
(0.3% (w/v)), Gum Arabic (0.3%(w/v)), and Arabinoxylane (0.3% (w/v))) and basic (Chitosan (0.1% (w/v)) moieties. 
Probiotic Pearls™ is a commercially available example containing a blend of gelatine and pectin 
in the outer layer to provide gastric acid protection to encapsulated probiotics (Nature’s Way 
Products, 2011a, 2011b). These systems are however more suitable for drug delivery to the colon. 
Nutrateric® is another commercially available coating formulation comprising a pH independent 
ethylcellulose film containing alginate (Colorcon®, 2019), which acts as pH dependent pore former. 
There are, however, some reports in literature of premature drug release in gastric conditions and 
much delayed drug release in small intestinal conditions post gastric emptying with alginate-based 
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formulations (Ali-Merchant et al., 2009; Czarnocka and Alhnan, 2015). Similar to synthetic 
polymers, the ionisation profile of the tested gums containing acidic moieties were not affected by 
different concentrations (data not shown). 
3.3.3.2. Gums containing basic moieties 
Chitosan was selected to represent gums containing basic moieties and the zeta potential profile 
of chitosan is shown in Figure 3.8. As expected, chitosan shows maximal ionisation at pH << pKa, 
similarly to EUDRAGIT E100, the commercially available reverse enteric polymer. At low pH (~2–
4) the amine groups in chitosan are fully ionised producing a maximum zeta potential, which drops 
as the pH increases and polymer becomes less ionised. The versatility of chitosan has prompted 
extensive studies in designing immediate release (Imai et al., 2000; Rasool et al., 2012) and 
controlled release (Imai et al., 2000; Shi et al., 2008; Yuan et al., 2010) drug delivery systems.  
3.3.3.3. Gluco and galactomannans 
Gluco- and galactomannans are widely used natural gums comprising mannose backbone with 
glucose or galactose side chains, respectively. These polymers are mainly composed of the two 
sugars which do not contain any ionisable moieties, and therefore are referred to as neutral 
polysaccharides. From this group of polysaccharides, Guar, Tara, Locust bean and Konjac gums 
were studied and their zeta profiles are shown in Figure 3.9. As expected, all four gums show a 
zeta potential near zero mV throughout the tested pH range. The absence of acidic or basic (i.e. 
ionisable) groups causes the gum to maintain neutrality, and therefore a pKa value estimation is 
not applicable.  
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Figure 3.9: Zeta potential vs. pH profiles of the studied sulphated (K-carrageenan) and neutral polysaccharides 
(Guar, Tara, Locust bean and Konjac gums) at concentration 0.1% (w/v). 
3.3.3.4. Sulphated polysaccharides  
Marine algae produce sulphate-containing polysaccharides, such as fucans, ulvans and 
carrageenans (Patel, 2012). Carrageenans have been studied for drug delivery purposes, showing 
promising uses both in immediate release (Ghanam and Kleinebudde, 2011) and in delayed 
release formulations (Picker, 1999). Figure 3.9 shows the ionisation behaviour of κ-carrageenan, 
a sulphated polysaccharide, which attained a highly charged ionised state (Zetamax= -30 mV) over 
the entire pH range used in this study (pH 2-10). Contrary to the weak acid groups (for instance 
carboxylic acids) found in other natural gums, these polysaccharides contain sulfonyl groups. 
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Sulfonic acids are strong acids and completely dissociate in water. This indicates that this group 
will have a very low pKa, with ionisation occurring throughout the tested pH range 
3.4. Final considerations 
Obvious limitations can be argued from the use of this technique especially when applied to 
polymeric materials: a) the folding of the polymeric chains and consequent exposure of functional 
groups may influence the readings and thus the pKa value determination; b) when the polymer is 
precipitated, the non-dissolved particles may interfere with the laser diffraction, providing false 
results; c) the stabilisation of the polymeric solutions is not achieved during the read times, possibly 
yielding unreal values. Despite the plausibility of these arguments, they may be countered by the 
highly reproducible results: although not all data is shown here, all polymers were measured 
numerous times, with data showing minimal deviation on the readings, as can be seen as an 
example in Figure 3.4; if the reproducibility between measurements is acceptable, either 
conformational changes of the polymeric chains and exposure of functional groups is unimportant, 
or it remains similar when conditions are identical. This would mean that when more biorelevant 
media are used, the obtained results will, as desired, more closely represent the polymer 
conformation in-vivo. Argument b) and c), regarding the phase when the polymer is precipitated 
and subsequent dissolution and stabilization of the solution can be simply argued by recalling that 
these are the condition the polymer encounters in-vivo: firstly in the stomach, where it is 
undissolved at a low pH, followed by a sharp increase of the surrounding pH at the duodenum 
bulb, leading to its quick ionisation. Additionally, regarding the possible interference of precipitated 
particles with the measurement, again the interpretation of the obtained results and their 
reproducibility provides a certain measure of assurance that acquired data is indeed reliable. 
The molecular weight of the used polymers is also worthy of consideration. The polymers used in 
this work were significantly different in terms of molecular weight, ranging from 18.000 to 125.000 
g/mol). The impact of these differences was not assessed, nor the influence of particle sizes. These 
two parameters would thus be considered in future development and work using this technique. 
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3.5. Conclusion  
This chapter describes the work involved in the development of a new methodology for the 
estimation of the pKa value of ionisable polymers based on zeta potential. The nature of the 
technique, in direct relation to the surface charge of the particle (in this case, a polymer) may 
provide more accurate information regarding the ionisation behaviour and pKa value than more 
commonly used potentiometric methods.  
This methodology allows for the ionisation study of both known and new polymeric materials, 
providing information regarding their potential use as gastroresistant materials. Addicionally, the 
use of more biorelevant media, mimicking the transitions in the GI tract (0.1M HCl and a biorelevant 
buffered system) will help understand the ionisation that possibly occurs in-vivo and obtaining this 
information for new polymers for enteric applications will lead to a better understanding of their 
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4.1. Introduction 
For enteric polymer dissolution to occur, a pH threshold needs to be surpassed, so that the polymer 
has sufficient ionised groups to start this process. Nevertheless, when referring to gastroresistant 
polymers, pH is not the only factor for a successful dissolution. Indeed, the medium has to be at a 
suitable pH to ionise the polymer, yet there is also the need for a buffering species that will 
constantly neutralise the H+ ions which would otherwise accumulate in the boundary layer. 
Information regarding specific dissolution mechanisms, and the true influence of the release media 
are scarce. Previous research has shown the limitations of using compendial phosphate-based 
release media (Liu et al., 2011), and indicated the importance of using a release medium with 
similar ionic composition and buffer capacity to biological fluids.  
According to the United States Pharmacopoeia and the European Pharmacopoeia, the 
recommended tested medium for enteric coated dosage forms is 50 mM pH6.8 phosphate buffer. 
However, as seen in Table 1.7, the buffer capacity of this buffer and of the intestinal fluid (23.1 and 
3.2 mmol/L/∆pH, respectively) is remarkably different. During the dissolution of an enteric polymer, 
a higher capacity buffer would more effectively remove the ions accumulating at the boundary 
layer, and hypothetically increase its dissolution rate, ultimately affecting the dissolution of the 
drug. Without constant removal of the produced H+ ions from the boundary layer by the buffer 
species, the accumulation of protons would lead to a decrease in pH in the vicinity of the polymer 
surface, halting its dissolution. Therefore, this discrepancy in buffer capacity of the recommended 
in-vitro dissolution media and the biological fluids will result in poor IVIVC as already reported by 
multiple studies (Al-Gousous et al., 2019, 2015; Garbacz et al., 2008; Karkossa and Klein, 2017; 
Merchant et al., 2014; Varum et al., 2014). This research thus aims to show the importance of 
buffer capacity in maintaining the appropriate pHm during the dissolution of enteric polymers when 
testing gastroresistant dosage forms and also deepen the understanding regarding the effect of 
both the buffer species and the ionised functional groups in polymer dissolution rates.  
To measure the dissolution rate, it is necessary to accurately measure polymer dissolution during 
a dissolution test, by quantifying the dissolved polymer over time. With this in mind, a methodology 
was developed based on the phenol-sulphuric acid (PSA) method. This method was firstly 
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described by Dubois et al.(1956), for the quantification of carbohydrates. The PSA method has 
since then been used and modified for the quantification of sugar in diverse samples (Chow and 
Landhäusser, 2004; Gerchakov and Hatcher, 1972; Jain et al., 2017; Kushwaha and Kates, 1981) 
and was more recently adapted by Ghori et al., (Ghori et al., 2014) for the quantification of HPMC 
released from the matrix of modified release tablets. Since this method was developed for the 
quantification of sugars, one of its limitations is the type of polymers it is able to detect. As 
previously described, the most commonly used enteric polymers are acrylic acid derivatives, 
cellulose derivatives and polyvinyl acetate phthalate (PVAP). This method allows for the 
quantification of cellulose derivatives, as these polymers can be broken down into simple sugars, 
therefore, different grades of HPMC-AS and HPMC-P were chosen to be used in this work. 
The method used by Ghori et al., (2014b) was modified to decrease sample processing times and 
to increase reproducibility, allowing for the quantification of HPMC-based gastro resistant 
polymers.  The dissolution rate of different enteric polymers was measured using the described 
method in a range of release media (phosphate and bicarbonate-based buffers) with different 
buffer capacities and was correlated with the determined pHm values and with previously reported 
pKa values (Chapter 3). Contact angle measurements were also performed for these polymers, 
using the same media as probes. Ultimately, the correlation between buffer capacity, buffer 
species, pHm, pKa, contact angle and dissolution rate of the polymers should allow for a better 
understanding of the mechanics of polymer dissolution.  
4.2. Materials and Methods 
4.2.1. Materials 
Hydrochloric acid (37%w/w), Phenol (99+%w/w), sulfuric acid (95%w/w, Extra Pure), Ethanol 
(99%+w/w, Extra pure) and the salts used to prepare the buffer solutions were acquired from Fisher 
Scientific (Leicestershire, UK). Triethyl citrate (≥99%w/w) and talc (powder, 10 μm) were 
purchased from Sigma-Aldrich (Dorset, UK). Sodium hydroxide (98.5-100.5%w/w, pellets) was 
obtained from VWR International (Leicestershire, UK). The enteric polymers used in this study 
(hypromellose acetate succinate (HPMC AS) LF and HF, hypromellose phthalate (HP) 50 and 55 
were kindly provided as samples from Shin-Etsu Chemical Co. (Chiyoda, Japan). 
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4.2.2. Preparation of polymeric disks 
Throughout the work, the samples used consisted of polymeric disks prepared by adding 
appropriate amounts of each formulation shown in Table 4.1 into the wells of a 12-well plate 
(Thermo Scientific™ BioLite). The solutions were then allowed to evaporate at 40°C, forming the 
disk samples with ~22 mm diameter at the bottom of the wells, which were then retrieved, cut and 
used for later testing.  
Table 4.1: Formulations used to prepare polymeric disks, based on Liu et al., (2011)  
HPMCAS LF / HF HPMCP HP-50 / HP-55 
Polymer weight 20 g Polymer weight 20 g 
Triethyl citrate 4 g (20%a) Triethyl citrate 2 g (10%a) 
SLS 0.6 g (3%a) Ethanol 230.4 g (80%b) 
Water 352 g Water 57.6 g (20%b) 
SLS:  Sodium lauryl sulphate; a: based on polymer weight; b: based on solvent weight 
4.2.3. Polymer dissolution studies 
4.2.3.1. Buffer capacity determination 
Phosphate and mHanks buffers with different buffer capacities (b) were used as dissolution media 
in this work. Buffer capacity is the ability of the buffer to resist changes in its pH and it can be 
measured by adding aliquots of acid/base to a buffer system and recording the corresponding pH. 
Buffer capacity (b) was calculated as reported previously by Liu and colleagues (2011) using 
equation 4.1.  
! = ∆"#∆$%    (Equation 4.1) 
Where AB is the increment in mol/L of the amount of acid or base added to produce a pH change 
of DpH in the buffer. b in all media was measured at a pH change of 0.5 units (DpH) on addition of 
the hydrochloric acid. This pH direction was chosen as it is the one relevant to our system, as 
during polymer dissolution H+ are produced and the pH will drop.  
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To determine b, all media were titrated from pH 6.8 to 6.3 with 0.1M HCl and the pH was recorded 
with each subsequent addition of titrant. The buffer capacity was modulated and determined by 
modifying the molarity of the main buffer specie of each medium. The composition of the prepared 
media is shown in Table 4.2. 
Table 4.2: Composition of the phosphate and bicarbonate buffers used 
 Concentration (mmol/L) 
Phosphate buffer  
KH2PO4 5.0 10.0 20.0 30.0 50.0 
NaOH 3.40 6.50 10.90 15.35 23.50 
 
Bicarbonate buffer      
NaHCO3 4.17* 10.0 20.0 30.0 40 50.0 
KH2PO4 0.441 0.441 0.441 0.441 0.441 0.441 
Na2HPO4·2H2O 0.337 0.337 0.337 0.337 0.337 0.337 
NaCl 136.9 131.07 121.07 111.07 101.07 91.07 
KCl 5.37 5.37 5.37 5.37 5.37 5.37 
MgSO4·7H2O 0.812 0.812 0.812 0.812 0.812 0.812 
CaCl2.2H2O 1.26 1.26 1.26 1.26 1.26 1.26 
*Liu et.al, 2011 
4.2.3.2. Dissolution rate of enteric polymers 
To assess the influence of buffer capacity on the dissolution rate of each polymer, dissolution of 
the produced sample disks was performed using phosphate (5mM, 25mM and 50mM) and 
bicarbonate (4.17mM, 20mM and 40mM) buffers. The samples were placed on a support, which 
allowed the dissolution to occur only from the exposed face of the disk. The support was then 
submerged in a beaker containing 1L of medium at 37°C, pH 6.8 and aliquots were collected at 
specific timepoints, with appropriate reposition of fresh medium (Figure 4.1A). The media was 
stirred using a magnetic stirrer, and across tests the conditions were kept consistent (magnetic 
stirrer, beaker, stirring plate, and stirring speed (30rpm)) to maintain a constant the flow of media 
across the surface of the disk. The collected aliquots were stored at 4°C for later analysis.  
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Figure 4.1: Schematic representation of the experimental layout used for the dissolution of polymeric disk (A) and 
for microenvironmental pH determination of polymeric disks (B).  
4.2.3.3. Quantification of enteric polymers 
The method used to quantify the dissolving polymer was adapted to improve the processing time 
and to minimise human and instrumental errors compared to previous studies (Dubois et al., 1956; 
Ghori et al., 2014). The first adaptation was to replace the test tube referred in previous studies 
with a 12-well microplate. The plate method had been previously adapted from Masuko et al., 
(2005), who used it for the quantification of sugars in samples.  
In this method, samples collected at each timepoint during dissolution of the polymeric disks were 
processed in triplicate, and each replicate sample was then measured in triplicate. Briefly, 1100 
µL of each sample was added in triplicate (A, B, C) to each column (1, 2, 3 and 4) of a Nunc™ 
Nunclon-D surface treated 12-well plate (Figure 4.2) followed by the addition of 3250 µL of 
concentrated sulfuric acid to each well. Next, 640 µL of 5% (w/w) phenol in 0.1M HCl was added 
and the mixture was homogenised using the pipette tip. The plate was then placed in a water bath 
at 30°C for 20 minutes. Subsequently, a sample from each well was transferred in triplicate to a 
Nunc™ 96-Well Microplate (as shown in Figure 4.2) and the absorbance was measured on a 
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Figure 4.2: Layout of the distribution of the samples (1-4) in triplicate (A-C) on the 12-wel microplate (Left) and the 
correspondent transfer to the 96-well plate for absorbance reading. Each 96-well plate can contain up to 10 samples 
processed in triplicate and read in triplicate.  
A calibration curve was performed for all tested polymers and a linearity was obtained for a range 
of concentrations from 0.1-20mg/L. The obtained calibration curves for all polymers showed a limit 
of quantification below 1mg/L (Table 4.3).  
Table 4.3: Linear regressions obtained from the calibration curves of the tested polymers with the respective limits 
of detection (LOD) and quantification (LOQ). 
AS-LF AS-HF HP-50 HP-55 
y = 0.0071x +0.0016 
R2 = 0.9997 
y = 0.0060x +0.0018 
R2 = 1 
y = 0.0044x +0.0018 
R2 = 0.9997 
y = 0.0061x + 0.0003 
R2 = 0.9998 
LOD = 0.3288 mg/L 
LOQ = 0.9964 mg/L 
LOD = 0.2668 mg/L 
LOQ = 0.8086 mg/L 
LOD = 0.3212 mg/L 
LOQ = 0.9733 mg/L 
LOD = 0.2723 mg/L 
LOQ = 0.8551 mg/L 
4.2.4. Contact Angle measurement 
Contact angle is influenced by the type of surface that is being tested, with higher angles occurring 
for more hydrophobic surfaces, and lower angles for more hydrophilic ones. Therefore, the sessile 
drop method was employed to determine the wettability of the polymers at different pH and in 
different buffers. An Ossila Goniometer (Ossila Ltd, Sheffield, UK) and specialised Ossila Software 
V2 were used to capture the contact angle variation and data analysis, respectively. Following the 
acquisition of the data, image analysis was performed to acquire information regarding the contact 
angle kinetics, where volume and basal area of the droplets were measured. For the measurement, 
15 µL droplets of the liquid probe, 0.1M HCl or buffer were released from a micro-syringe from a 
constant height (3 cm) for consistency purposes (Figure 4.3). To assess the different wettability of 
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the polymers throughout a typical dissolution study, the media used in this study were 0.1M HCl 
pH 1.2, pH 6.8 phosphate buffer (5 mM, 25 mM and 50 mM) and pH 6.8 bicarbonate buffer (4.17 
mM, 20 mM and 40 mM) (vide Table 4.2). The monitored contact angle variations were then plotted 
against time. All the experiments were conducted at room temperature.  
 
Figure 4.3: Example of contact angle measurement with a drop of media on polymeric disk sample, analysed using 
Ossila Contact Angle software. 
4.2.5. Microenvironment pH measurements 
Using a similar experimental layout as in section 4.2.3.2, polymeric disks were placed on the same 
support, and two pH electrodes were used: one to measure the bulk pH of the medium (HI-
1090B/5, Hanna Instruments, Bedfordshire, UK) and a surface pH electrode (In-Lab Surface Pro-
ISM, Mettler-Toledo, Leicester, UK) to measure the pHm (Figure 4.1B).  
The surface electrode was placed at 100 µm from the polymeric disk and the distance was kept 
constant throughout the various measurements. This was achieved by placing a spacer between 
the polymeric disk and the surface electrode which was then removed before each measurement. 
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To verify the influence of the buffer capacity of the medium on the pHm, phosphate buffers (5 mM, 
25 mM and 50 mM) and bicarbonate buffers (4.17 mM, 20 mM and 40 mM) at pH 6.8 were used.  
4.3. Results and discussion 
4.3.1. Buffer capacity determination 
Buffer capacities were determined for each buffer as described above, and the results are 
summarised in Table 4.4. The determined b for phosphate buffer 50 mM and bicarbonate buffer 
4.17 mM are in agreement with the ones determined by Liu et al., (2011). Figure 4.4 shows the 
relationship between buffer concentration and the determined buffer capacity. As expected, b 
increases with concentration, however this effect seems more pronounced for bicarbonate buffer, 
which increases at a higher rate than the phosphate buffer.  
Table 4.4: Determined buffer capacities (b) for phosphate and bicarbonate buffers at different concentrations. 
Phosphate buffer Bicarbonate buffer 
Buffer concentration 
(mM) 




Buffer capacity, b 
(mmol/L/ΔpH) 
5 2.32 ± 0.06 4.17 2.31 ± 0.03 
10 4.58 ± 0.15 10 5.97 ± 0.13 
20 9.97 ± 0.07 20 12.30 ± 0.42 
30 14.67 ± 0.30 30 18.86 ± 0.21 
50 26.08 ± 0.24 50 31.66 ± 0.99 
Note: Measurements performed with 100 mL of sample, titrated from pH 6.8 until pH 6.3 with 0.1M HCl. Average ± STD (n=3). 
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Figure 4.4: Relationship between buffer concentration and buffer capacity (b) for phosphate and bicarbonate 
buffers. 
4.3.2. Quantification of enteric polymers 
The used method was developed to increase efficiency in sample processing for the quantification 
of HPMC-based polymers compared to the original reported method (Dubois et al., 1956). In 
previous work, samples had to be processed individually, one in each test tube and reagents had 
to be added carefully to test tubes with “the stream of acid being directed against the liquid surface 
rather than against the side of the test tube” (Dubois et al., 1956). By adapting the method to be 
carried out in a microwell plate, time efficiency was gained by allowing samples to be processed 
in parallel, with the reagents being added using micropipettes. In the original method, after the 
addition of all the reagents, samples would stand for 10 min, were shaken and placed in a water 
bath for 10-20 min. Ghori et al., (2014) reports the use of a vortex stirrer to improve sample mixing, 
thus decreasing standing time. Nevertheless, this technique required an average of 2-3 min to 
process each sample (excluding incubation in the water bath). The optimisation of the microwell 
method allowed for a processing time of around 7-8 min per plate (i.e. 12 samples), reducing 
processing time to around one fifth of the original time. Additionally, the space occupied by the 
materials was also improved, as test tubes with the corresponding supports are much bulkier than 
a simple 12-well plate. Considering the reagents used (sulphuric acid and phenol) safety measures 
indicate that this kind of reaction should occur within a fume-hood, where space to work is even 
more important. Microplates being easily stacked warrant a safer environment to work than glass 
y = 0.5278x - 0.6164
R² = 0.9986
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test tubes. Finally, the reagent volumes were also reduced, leading to less liquid waste especially 
relevant in this reaction due to the presence of phenol in the waste, requiring specialist and 
separate waste treatment. Regarding the absorbance readings, a greater time efficiency was 
achieved, with 96-well plates being read within seconds, as compared to much more laborious 
readings using UV-Vis spectrophotometers. In less than 10 seconds, 96 samples can be read, 
compared to an average of 1 minute per sample using traditional UV-Vis spectrophotometers and 
cuvettes. 
4.3.3. Dissolution rate of enteric polymers 
The dissolution rate of the tested polymers was calculated and a linearity between polymer 
dissolution rate and buffer capacity was found (Figure 4.5, Table 4.6). As expected, the dissolution 
rate rises as the buffer capacity of the medium increases. The increased buffer capacity allows for 
more effective removal of accumulated H+ ions at the boundary layer which arise from polymer 
ionisation (Figure 1.11). With the removal of these ions from the boundary layer, the 
microenvironmental pH is maintained above the polymer’s dissolution pH threshold. However, with 
lower buffer capacities the less extensive removal of H+ ions will lead to a lower pH at the boundary 
layer, hampering polymer dissolution (i.e. low dissolution rate). 
Table 4.5: Dissolution rate (mg/min/cm2) of tested polymers in different buffer media. 
 Phosphate Bicarbonate 
 5 mM 25 mM 50 mM 4.17 mM 20 mM 40 mM 
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Figure 4.5: Correlation between dissolution rate and buffer capacity for each tested polymer in phosphate (filled 
symbols) and bicarbonate (empty symbols) buffers. 
Table 4.6: Linear regression analysis of the effect of buffer capacity of bicarbonate and phosphate buffers on the 
dissolution rate of the studied polymers (in reference to Figure 4.5). 
 Phosphate Bicarbonate 
HP-50 y = 0.021	(±7.19 × 10
!")	x + 0.083	(±	1.19 × 10!#)	 
2$ = 1.000 
3 = 0.023	(±1.44 × 10!#)	5 + 0.184(±	2.37 × 10!$)	
2$ = 0.9962 
HP-55 y = 0.020	(±1.62 × 10
!#)	5 + 0.068	(±	2.70 × 10!$)	
2$ = 0.9934 
3 = 0.025	(±8.59 × 10!%)	5 + 0.086	(±	1.41 × 10!$)	
2$ = 0.9988 
AS-LH y = 0.021	(±2.38 × 10
!%)	5 + 0.083	(±	3.95 × 10!#) 
2$ = 0.9999 
y = 0.025	(±3.10 × 10!")	5 + 0.111	(±	5.09 × 10!%) 
2$ = 1.000 
AS-HF y = 0.006	(±6.98 × 10
!%)	5 + 0.030	(±	1.16 × 10!$) 
2$ = 0.9866 
3 = 0.008	(±6.28 × 10!%)	5 + 0.050	(±	1.03 × 10!$)	
2$ = 0.9944 
Interestingly, when comparing buffers with similar buffer capacities, dissolution rates are higher for 
bicarbonate buffer than phosphate buffer for all polymers studied. Also worthy of remark is the 
capacity of bicarbonate buffer to discriminate different dissolution rates between all polymers, 
whereas when using phosphate buffer only AS-HF is significantly different from the other three 
polymers. Additionally, statistical analysis (two-way ANOVA) indicated that in the studied dataset, 
the buffer concentration contributed 4x more to the variance than polymer type. This is even further 
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intensified when excluding AS-HF from the analysis, revealing that in this case, buffer 
concentration is accountable for 97% of variance. Even though polymers contribute to the variance 
(i.e. polymer type affects the obtained dissolution rate) the buffer concentration is thus the main 
cause contributing to the difference in dissolution rates. Therefore, and in accordance with the 
polymers’ dissolution pH thresholds (see Table 3.1), the dissolution rate of the tested polymers in 
bicarbonate ranks as follows: HP-50 > AS-LF > HP-55 > AS-HF.  
At all tested concentrations of phosphate and bicarbonate buffers, AS-HF has shown the lowest 
dissolution rate. This is not at all unexpected and may be explained by its reported dissolution pH 
threshold. This polymer is reported to dissolve above pH 6.8, which is exactly the pH at which the 
test was conducted. However, as this polymer ionises and protons are released and accumulating 
at the boundary layer between the polymer and the medium, a drop in pH occurs, as the capacity 
of the buffer to remove the generated H+ ions is limited. Since the pH of the medium is so close to 
the polymer dissolution pH, small drops in the pH immediately affect the dissolution of the polymer, 
which in turn causes the low dissolution rate of AS-HF. This effect is not as pronounced for the 
other polymers, since their dissolution pH thresholds are lower, allowing for broader pH fluctuations 
to occur before impacting dissolution. There is further discussion on this polymer in section 4.3.4 
exploring how the higher dissolution pH affects the microenvironmental pH surrounding the 
polymer surface. 
Differences in dissolution rates of drugs using different media have been previously reported and 
explained by Sheng and colleagues (2009). The authors studied how the dissolution rate of two 
drugs was influenced by the use of different buffers, at different concentrations. Similar to results 
found in this study, Sheng and colleagues verified that increasing bicarbonate buffer 
concentrations from 5 mM to 15 mM increased the dissolution rate of the studied drugs. The 
authors also found that although tested at the same pH and buffer concentration, the dissolution 
of both drugs in phosphate and bicarbonate was inherently different. Unlike Sheng and co-workers 
who used buffer concentration as the comparable variable, in this work the emphasis was on buffer 
capacity. Results showed that when using phosphate and bicarbonate buffers at different 
concentrations yet with the same buffer capacity (e.g. 50 mM phosphate buffer and 40 mM 
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bicarbonate buffer), the dissolution rate was higher in bicarbonate. This observation further 
corroborates Sheng’s results, i.e., although pH and either buffer concentration or buffer capacity 
may be kept constant, there can still be differences in the dissolution rates when using different 
buffers. The authors hypothesise that chemical and physical dissimilarities between phosphate 
and bicarbonate, especially the pKa and the diffusion coefficient, give rise to the different 
performances of these buffers. The reported (Sheng et al., 2009) diffusion coefficient for the H2PO4-
/HPO42- ions is 11.5x106 cm2/s, whereas H2CO3 and HCO3- have higher diffusion coefficients 
(19.25x106 cm2/s and 12.35x106 cm2/s, respectively). Furthermore, the authors attempted to 
design a surrogate phosphate buffer for bicarbonate by theoretical analysis, using the film model 
and the reaction plane model (Sheng et al., 2009). This allowed them to select a concentration of 
phosphate buffer which would perform similarly to a 15 mM bicarbonate buffer, yielding similar 
dissolution rates for the class II drugs. However, results have shown that not only the buffer 
chemistry is important, but also the entity being dissolved. For ketoprofen, 13.0 mM phosphate 
buffer was used as a surrogate buffer, which yielded a dissolution rate that was 86% of the one 
obtained using a 15 mM bicarbonate buffer. As for indomethacin, a 3.5 mM phosphate buffer was 
used, and the dissolution rate was 108% of that obtained using the 15 mM bicarbonate buffer. Both 
drugs performed quite differently using the studied buffers, with indomethacin being more sensitive 
to phosphate than ketoprofen. The authors further suggest that a surrogate phosphate buffer 
should therefore be modelled for each drug on a case-by-case basis using the suggested models.  
The results obtained in this study can be explained using the same rationale, with the differences 
between phosphate and bicarbonate being due to the intrinsic characteristics of these buffers, such 
as the pKa and the diffusion coefficient. As previously mentioned, polymers and small molecules 
greatly differ in terms of dissolution mechanics. The dissolution of solid polymeric materials 
involves an important first step, the diffusion of the solvent through the polymeric entangled chains. 
Higher diffusion coefficients may then indicate quicker diffusion of the medium through the 
polymeric chains, increasing the speed of the dissolution process, thus increasing the dissolution 
rate.  
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4.3.3.1. Case study: Translating polymer dissolution rate to effective drug release 
The study of dissolution rate of enteric polymers is ultimately linked to the need to understand how 
this may affect drug release. In Chapter 2, enteric hard capsules were prepared, and prednisolone 
release was measured under different buffers. As mentioned before, clear differences in the drug 
release were found when using the compendial 50 mM pH 6.8 phosphate buffer and a more 
biorelevant 4.17 mM pH6.8 bicarbonate buffer (refer to Table 4.2 for more details regarding the 
buffer) (Figure 2.6). When tested in phosphate buffer, a quick drug release was observed from 
both AS-LF and HP-55 capsules, with these two polymers showing very similar lag times until 1% 
of drug release occurred (vide Table 2.6). Similarly, the reported dissolution rate for these two 
polymers was shown to be indistinguishable when tested in the same 50 mM pH6.8 phosphate 
buffer. However, when tested using the 4.17 mM pH6.8 bicarbonate buffer, there was a clear 
distinction in the drug release profile of the two polymers, with higher lag times for HP-55 than AS-
LF (67.5 and 18.2 min, respectively, vide Table 2.6). This same distinction was observed when 
measuring the dissolution rates of these two polymers using the same buffer with AS-LF showing 
a higher dissolution rate than HP-55, consequently affecting the drug release from the capsules.  
These results confirm how polymer dissolution rate may directly affect drug release from an enteric 
dosage form. Additionally, this also confirms the feasibility of using filled enteric hard capsules of 
different materials to study the effect of different media on the drug release. 
4.3.4. Microenvironmental pH measurements 
Considering how the buffer capacity influences the dissolution rate of the polymers by removing 
accumulated H+ ions from the diffusion layer, the measurement of the pHm over time and under 
different media should provide a good indication of how the medium affects the mechanics behind 
polymer dissolution. The performed study aimed to measure the pH at the diffusion layer 
investigating the influence of the buffer capacity on the pHm using phosphate (5 mM and 50 mM) 
and bicarbonate (4.17 mM and 50 mM) buffers at pH 6.8 (Figure 4.6).  
The difference between 5mM and 50mM phosphate buffer was immediately noticeable. The higher 
buffer capacity of the 50mM phosphate buffer was enough to hold the pH of the medium in the 
vicinity of the dissolving polymer close to the original pH, never dropping below ~6.5. Throughout 
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the tests with both buffers and at both concentrations, the bulk pH probe registered a pH value of 
6.8 ± 0.05. However, when using 5 mM phosphate buffer, distinctions between polymers were 
immediately more noticeable, as the pH dropped sharply. As shown in Table 4.7, AS-HF had the 
highest pHm after 30 min, followed by AS-LF, HP-55 and HP-50. 
Table 4.7: Determined pHm for the tested polymers in phosphate and bicarbonate media, after 30 min of exposure. 
 Phosphate Bicarbonate 





































Figure 4.6: Measurement of the microenvironmental pH (pHm) of the tested polymers under phosphate (filled symbols) or bicarbonate (empty symbols) buffers at high (solid lines) 















































































hapter 4      M
echanistic Insights: C






Chapter 4 Mechanistic Insights: Causes, Effects and Ultimate Regulation of Polymer Dissolution 
92 
Measurement of the pH near the surface of dissolving enteric polymers has been reported using a 
fluorimetric technique (Harianawala et al., 2002). The study was performed on HP-50 and HP-55 
with stirred and unstirred conditions, and the media were 50 mM phosphate buffers at pH 6.5 and 
7.0. Although the buffers do not exactly match those in the present work, there is a similarity which 
allows for comparison of some data. In Harianawala’s study, the fall in pH near the polymer surface 
was higher for HP-50 than for HP-55, which correlates with the data obtained in this thesis. 
Furthermore, at pH 6.5, after 30 min the surface pH for HP-50 fell to ~6.1 and for HP-55 to ~6.3, 
which are much lower than the obtained in this work. These differences could be due to the method 
used to determine pH. 
The smallest fall in pHm was for AS-HF. As discussed before in section 4.3.3, AS-HF was also the 
polymer with the lowest dissolution rate. The reported dissolution pH threshold for AS-HF is 6.8, 
the highest threshold amongst the tested polymers and the same pH at which the test takes place. 
This may explain the smaller changes in pHm and also the smallest variation in the dissolution rate. 
When using a buffer with high buffer capacity (e.g. 50 mM phosphate buffer), the pH near the 
polymer surface will remain very close to the dissolution pH threshold of this polymer, however 
never surpassing it. So, at a pH near 6.8, AS-HF will dissolve, albeit much slower than the other 
tested polymers which have much lower dissolution pH thresholds. When the buffer capacity is 
decreased (e.g. 5 mM phosphate buffer), the generated H+ are removed from the boundary layer 
more slowly, causing the pHm to drop, thus hampering its already slow dissolution. With a lower 
dissolution rate, less H+ are produced, and eventually the buffer restores the equilibrium between 
produced and removed H+ ions at a pH near 6.   
4.3.5. Contact angle measurements 
Contact angles were measured using different concentrations of phosphate and bicarbonate buffer 
as probes. The results are summarised in Figure 4.7, showing observable differences between the 
polymer/buffer systems. Additionally, an image analysis was performed where the droplets were 
measured and their volume and basal area were calculated as reported by Farris et al,.(2011). 
Figure 4.8 – 4.11 show the evolution of the volume and the basal area of the droplet over the period 
of time tested for the different polymers.  
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Figure 4.7: Contact angle determination for the tested polymers (AS-HF, AS-LF, HP-55 AND HP-50) using 0.1 M 
HCl, phosphate (left) and bicarbonate (right) buffers at different concentrations. 
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Figure 4.8: Variation of volume and basal area of the droplets during contact angle measurements of AS-HF using 
different concentrations of bicarbonate (left) and phosphate (right) buffers. 
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Figure 4.9: Variation of volume and basal area of the droplets during contact angle measurements of AS-LF using 
different concentrations of bicarbonate (left) and phosphate (right) buffers. 
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Figure 4.10: Variation of volume and basal area of the droplets during contact angle measurements of HP-50 using 
different concentrations of bicarbonate (left) and phosphate (right) buffers. 
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Figure 4.11: Variation of volume and basal area of the droplets during contact angle measurements of HP-55 using 
different concentrations of bicarbonate (left) and phosphate (right) buffers. 
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4.3.5.1. Influence of buffer concentration 
Buffer concentration directly influences b, contributing to buffer systems more capable of 
countering small additions of acids or bases, thus maintaining the desired pH of the medium. In 
this experiment, buffer concentration (and thus buffer capacity) has shown to affect the contact 
angle, and therefore the wettability of the studied polymers. Figure 4.4 and Table 4.8 show that in 
all tested polymers, using both types of buffer, an increase in buffer concentration was translated 
to a decrease of the contact angle. In Table 4.8 the initial contact angle (i.e. the contact angle at 
the time of first contact between the droplet and the polymer(!0)) and the contact angle after 30 
seconds (!30) is shown. For all polymers, the !0 and !30 were the highest when using 0.1M HCl, 
and in general !0 and !30 decrease with increasing concentration of buffer. The probes in this test 
were aqueous solutions, therefore a decrease in the contact angle indicates an increased 
hydrophilicity of the tested surfaces. As the polymers are not soluble in 0.1M HCl, a higher 
hydrophobicity is expected using this medium, as no ionisation of the polymeric chains is occurring. 
However, when using the buffers as the testing media polymer ionisation occurs, and as seen 
before, higher buffer capacities translate to higher dissolution rates, caused by the increased 
capacity of the buffer to remove the ions from the boundary layer. Higher dissolution rates indicate 
a higher generation of H+ ions, and therefore an increased hydrophilicity. During the sessile drop 
test, only a small volume of buffer is placed onto the polymeric surface, thus the removal of protons 
to the bulk solution is somewhat more limited, due to the reduced volume and lack of agitation. 
Nonetheless, although there is diminished removal of the generated H+ ions, a buffer with higher 
b is more capable of countering the change in pH, maintaining the pHm stable for longer. This leads 
to more extensive ionisation of the polymeric chains, increasing its hydrophilicity, thus decreasing 
contact angle.  
Additionally, from Figure 4.8 – 4.11, it is possible to observe that with higher concentrations of 
buffer, higher losses in volume occur. This drop in volume is explained by the absorption of the 
buffer by the film. With higher concentrations, higher dissolution rates are observed, indicating a 
possible higher rate of diffusion of the buffer, which leads to to higher volume losses. Also, when 
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using 0.1M HCl an insignificant loss of volume occurs, indicating that there is little absorption of 
this media, correlating with the non-dissolution of the polymers in acidic environment.  
Table 4.8: Obtained contact angles for the tested polymers at the initial time of contact (!0) and after 30 seconds 





5mM 25mM 50mM 4.17mM 20mM 40mM 
AS-LF 
!0 
53.75 ± 5.84 
!30 
44.70 ± 1.03 
!0 
49.37 ± 1.80 
!30 
11.19 ± 0.48 
!0 
39.68 ± 1.99 
!30 
8.96 ± 0.75 
!0 
38.52 ± 4.93 
!30 
4.54 ± 0.44 
!0 
39.96 ± 0.08 
!30 
10.36 ± 0.20 
!0 
37.38 ± 0.16 
!30 
7.97 ± 0.07 
!0 
36.22 ± 0.55 
!30 
2.11 ± 1.24 
AS-HF 
!0 
46.12 ± 0.73 
!30 
20.53 ± 0.54 
!0 
42.24 ± 0.67 
!30 
10.72 ± 1.20 
!0 
34.06 ± 1.00 
!30 
10.37 ± 0.24 
!0 
38.07 ± 0.16 
!30 
9.50 ± 0.56 
!0 
40.98 ± 6.38 
!30 
13.68 ± 1.73 
!0 
38.4 ± 1.18 
!30 
8.76 ± 1.73 
!0 
35.53 ± 0.97 
!30 
5.69 ± 0.76 
HP-50 
!0 
71.38 ± 0.38 
!30  
65.60 ± 0.42 
!0 
66.73 ± 0.25 
!30 
63.83 ± 0.61 
!0 
64.03 ± 1.38 
!30 
51.92 ± 0.42 
!0 
67.09 ± 0.73 
!30 
49.56 ± 0.35 
!0 
68.76 ± 0.57 
!30 
51.04 ± 0.11 
!0 
64.69 ± 0.26 
!30 
39.01 ± 0.23 
!0 
63.83 ± 1.04 
!30 
35.39 ± 0.35 
HP-55 
!0 
75.46 ± 1.50 
!30 
65.42 ± 0.71 
!0 
68.19 ± 0.55 
!30  
59.50 ± 0.05 
!0 
61.27 ± 1.96 
!30  
53.38 ± 0.30 
!0 
66.48 ± 0.63 
!30  
52.74 ± 0.81 
!0 
67.45 ± 0.49 
!30  
46.61 ± 0.43 
!0 
69.54 ± 0.51 
!30  
38.89 ± 1.56 
!0 
67.27 ± 0.23 
!30  
36.71 ± 0.07 
4.3.5.2. Influence of polymer type  
Contact angle is influenced by the type of surface that is being tested, with higher angles occurring 
for more hydrophobic surfaces, and lower angles for more hydrophilic ones. Therefore, the type of 
polymer being tested will influence the corresponding contact angle of a drop on its surface due to 
the differences in their constitution. The four polymers tested share a similar structure (HPMC), 
differing in their specific functional groups which provides them with different characteristics, of 
most importance in this case, their dissolution pH. HPMC-P (HP50 and HP-55 in this study) 
contains phthalate groups (vide Table 3.4), whereas HPMC-AS contains acetyl and succinoyl 
groups, with the latter being the ionisable group, as acetate only contains one -COOH group which 
is bonded to the polymer backbone and thus not available for further ionisation. As mentioned, the 
contact angle of a drop on a surface depends on the hydrophobicity/hydrophilicity, which is 
influenced by the functional groups present in the material, in this case a polymer. Phthalate and 
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succinate have very different Log P values (0.73 and -0.59, respectively (Hansch et al., 1995)), 
which indicates different hydrophilicity of these polymers, with phthalate being more hydrophobic 
than succinate. This would lead to higher contact angle values for HP-50 and HP-55 than for AS-
LF and AS-HF, which is indeed reported in Figure 4.7 and Table 4.4. For the same buffer type and 
concentration, HP-50 and HP-55 have higher contact angles than AS-LF and HF, in agreement 
with the above-mentioned chemistry of these polymers.  
Regarding the shape of the droplets, Figure 4.8 – 4.11 show that for HPMC-AS a higher variation 
of the basal area occurs, indicating a much higher spreading of the droplet than for HPMC-P, 
correlating to the observed higher contact angles for HPMC-AS polymers. The increasing basal 
area and the lower loss of volume observed for HPMC-P polymers indicates that more spreading 
and lower absorption is occurring in these polymers when compared to HPMC-AS polymers. 
Higher volumes losses are seen for HPMC-AS polymers, indicating a higher absorption of the 
droplets by these polymers. This may be related to possible differences in the  porosity of the films 
(which was not measured), but may also be explained by a higher diffusion of the buffer for HPMC-
AS. Due to the chemical differences of the two groups of polymers (HPMC-AS and HPMC-P), a 
higher affinity of these aqueous solutions for HPMC-AS is possible, as explained before.  
When comparing two polymers of the same type (HP-50 and HP-55 or AS-LF and AS-HF) for the 
same buffer species, interestingly there seems to be no significant differences in contact angle 
between HP-50 and HP-55s but AS-HF shows higher contact angles than AS-LF. The similarity in 
contact angle between HP-50 and HP-55 may be related to the number and the chemistry of the 
phthalyl functional groups. HP-55 contains the most groups (27.0-35.0%, vs. 21.0-27.0% for HP-
50, vide Table 3.4), and since phthalyl is a more hydrophobic group, a higher percentage should 
lead to higher hydrophobicity, and thus higher contact angle. However, this is not the case, as 
seen the obtained contact angles are very similar between the polymers. With a higher number of 
ionisable groups, HP-55 generates a higher charge on the surface of the polymer, as mentioned 
in Chapter 3 (vide Table 3.4), and therefore this increased charge translates in an increased 
hydrophilicity. A possibility for the similarity between these two polymers may thus lay on the 
balance between number of hydrophobic groups and generated surface charge.  
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In the case of AS polymers, the difference also arises due to the number and type of functional 
group present, but in this case the functional group (succinoyl) is hydrophilic. Therefore, as AS-LF 
contains a higher % of succinoyl groups (14-18%, vs. 4-8% for AS-HF, vide Table 3.4), a more 
hydrophilic surface should be expected for this polymer, leading to lower contact angles. The 
observed values for contact angle also correlate with the Zetamax values obtained, with AS-HF 
having shown lower charge than AS-LF (-8.76mV and -15.41mV, respectively). The nearly 2-fold 
higher charge shown by AS-LF will also contribute to the increased hydrophilicity of this polymer, 
and the lower recorded contact angle. 
4.3.6. Influence of buffer type 
During contact angle measurements, clear differences were seen when using phosphate or 
bicarbonate buffers. In general, tests using bicarbonate yielded lower contact angles than when 
using phosphate buffers. Following the same rationale as above, lower contact angles indicate 
higher hydrophilicity, potentially indicating a higher degree of ionisation. Additionally, higher 
volume losses and increased spreading (higher basal area) are observed when using bicarbonate 
buffers (Figure 4.8 – 4.11). These results are in accordance with the obtained dissolution rates for 
these polymers under the tested conditions. In bicarbonate, all polymers have an increased 
dissolution rate, indicating a higher extent of ionisation, leading to a more hydrophilic surface, 
therefore decreasing the contact angle. The reasons for the increased dissolution rate were 
already discussed in the section 4.3.3.  
Worthy of remark is the lack of significant difference in the observed contact angle for AS-HF when 
in contact with different concentrations of phosphate buffer, whereas AS-LF shows lower contact 
angle values with increasing concentration of this buffer. Again, the dissolution rate could play a 
role in this matter, with AS-HF still having a much lower dissolution rate than AS-LF, even with 
phosphate buffer at 50mM. The low dissolution rate would thwart the generation of protons (i.e. 
the ionisation of further functional groups). Contact angle may be affected by the charged 
functional groups, and at higher buffer capacities the generation of protons will be increased. 
However, the increase in the number of protons occurs at a scale that allows for the increased 
buffer capacity to neutralise the generated ions. This would cause minimum changes in the 
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experienced contact angle, causing a minimum limit for contact angle to be reached. This minimum 
seems to have been reached for this polymer during this test as observed in Figure 4.7. This is not 
the case for AS-LF, where a more significant increase in the dissolution rate is observable with the 
increase in buffer concentration (Table 4.5), which would encompass more deprotonated ionisable 
groups. Again, a higher quantity of ionised groups instigated by higher buffer concentrations 
suggests higher hydrophilicity, and therefore lower contact angles. 
Additionally, the buffer chemistry may also pose an effect with these polymers, with different 
substances reacting differently to each buffer species. In Sheng’s and colleagues (2009) work, 
indomethacin and ketoprofen responded differently to phosphate and bicarbonate buffers, 
requiring reduction in phosphate molarity to manifest the same intrinsic dissolution rate as in 15mM 
bicarbonate buffer. Moreover, the concentration of phosphate buffer used for indomethacin was 
much lower than for ketoprofen (3.5 mM and 13.5 mM, respectively), showing that the different 
drugs perform differently in the media due to, and as stated by the authors, intrinsic differences in 
the chemistry of the molecules.  
Finally, when using the highest concentration of bicarbonate buffer, a near zero contact angle was 
registered for AS-LF. Figure 4.9 shows that when using 40mM bicarbonate buffer, there is approx. 
60% of volume loss, with the basal area of the droplet greatly increasing as well. The very low 
contact angle can be thus explained by the absorption of the droplet occurring for AS-LF. The 
analysis of the volume of the droplets show that for HPMC-AS, a higher volume loss occurs when 
using bicarbonate buffer then when using phosphate buffer. These polymers may be reacting with 
more affinity to bicarbonate buffer, which by generating higher dissolution rates, allows a higher 
diffusion of the buffer through the gel-layer of the polymer, leading to higher volume losses, i.e. 
higher absorption. Additional explanations may be related to the porosity of the polymeric film 
(which was not measured) with high porosity causing the higher absorption of the droplet.  
4.3.7. Acid uptake: insights from contact angle kinetics  
The contact angle kinetics provides useful insights into how a fluid interacts at the surface of a 
polymeric film and can deliver useful clues into acid uptake and gastroresistance exhibited by 
various polymers. Conventionally, acid uptake is evaluated in gastroresistant dosage forms to 
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access how much acid diffuses through the enteric polymeric film during the acid stage of the 
compendial dissolution test. This test is conducted by weighing the tested tablets before and after 
2h in 0.1M HCl and the acid uptake is given as a percentage of the weight gained during this 
period.  
The contact angle kinetics of various polymers were studied in 0.1M HCl and provide palpable 
information on wettability of the polymeric films in acidic environment of the stomach. As 
mentioned, the obtained contact angle for all polymers was highest when using acid than in buffers, 
however, after analysing the obtained images and calculating the volumes changes during the test, 
it can be seen that a small percentage of acid was absorbed through these films which can be 
seen by the reduction of the drop volume on surface of the polymeric film with time (Figure 4.12). 
Since the fluid contact area with the film did not change significantly during this period, this confirms 
that the loss of volume is not mainly due to the spreading of the droplet over the film surface but 
as a result of absorption/penetration into the films.  
 
Figure 4.12: Variation of volume during contact angle measurements using 0.1M HCl as testing medium.  
The acid uptake of these polymers has been previously studied by Liu and colleagues (2011) and 
interestingly the results correlate with the variations in volumes obtained during contact angle 
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kinetics. In Liu’s study, HPMC-P had a lower acid uptake than HPMC-AS, and a similar trend can 
be seen in Figure 4.12, with HP-50 and HP-55 showing a less volume variation than AS-LF and 
AS-HF. Additionally, HP-55 has shown a lesser loss in volume than HP-50, which is also in 
agreement with Liu’s findings where HP-55 exhibited less acid uptake than the HP-50 (2.1 and 
2.8%, respectively). Similarly, Liu et al., (2011) also reported that a higher acid uptake occurs with 
AS-LF which corresponds to a higher decrease in volume in our studies. Therefore, the contact 
angle kinetics can be a useful tool to study the acid uptake from pH responsive polymeric films 
employed in modified release dosage forms. Future experiments should aim to directly relate the 
acid uptake of these polymers on coated tablets in relation to the contact angle kinetics on tablet 
surface and implications in subsequent drug release in acid and buffer.  
4.4. Conclusion 
The effect of buffer capacity on the dissolution of different polymers was investigated. For this, an 
adaptation of the previously reported PSA quantification technique was developed for the direct 
quantification of HPMC-based polymers, more specifically those employed in enteric coatings. This 
technique was used to assess the dissolution rate of some of these polymers, and it will allow for 
the direct quantification of dissolving coatings from enteric dosage forms during dissolution tests. 
Additionally, the effect of the buffer capacity in the regulation of the microenvironmental pH 
surrounding a dissolving polymer was shown to directly dictate the dissolution rate of acidic 
polymers, by actively regulating the pHm and influencing its dissolution. The dissolution of 
polymeric materials is a complex process ruled not only by the ionisation of their functional groups, 
but also by their nature and possible interactions. Knowledge of the pKa value of these polymers 
may be useful when studying dissolution behaviour, however it is necessary to know the nature 
and the number of functional groups to accurately predict their ionisation and applicability in 
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5.1. Deciphering the challenge: mechanistic insights into polymer dissolution 
and subsequent drug release  
After examining and discussing the obtained results in detail for the dissolution rate, 
microenvironmental pH and contact angle for all polymers, a broader discussion is needed 
covering all aspects of the tests and correlating these with other properties of the polymers, such 
as their constitution, estimated pKa and DpHT. Ultimately, the goal is to understand the factors 
governing polymer dissolution. Contact angle kinetics has provided insight into hydrophilicity of the 
polymeric surface and corroborated the results obtained for the pHm and the polymer dissolution 
rate.  
It would be acceptable to assume that polymer dissolution is directly linked to the extent of 
ionisation of an enteric polymer, but other factors also play a role and the relationship is not as 
straightforward as usually perceived. Using HP-50 and HP-55 in low buffer capacity bicarbonate 
buffer as an example, the first has a higher dissolution rate (0.220±0.023 mg/min/cm2 vs. 
0.134±0.009 mg/min/cm2, vide Table 4.5). The above-mentioned rationale would lead to the 
conclusion that HP-50 is more extensively ionised than HP-55. However, at the tested pH, both of 
these polymers should attain the same degree of ionisation, as they are more than 2 units above 
their estimated pKa (vide Figure 1.6 and Table 5.1). They are also well above their reported DpHT, 
therefore the difference in dissolution rate ought not to be related to a possible effect of the pH of 
the media.  
Regarding the pHm, HP-50 has a lower value after 30 minutes, reinforcing that ionisation was more 
extensive for HP-50, producing more H+ ions which would accumulate at the diffusion layer. 
Ultimately, a contradiction seems to arise: the extent of ionisation ought to be the same since both 
polymers are more than 2 units above the pKa, yet it is not, as shown by the difference in pHm.  
A possible explanation could reside in the percentage of functional groups each polymer contains, 
whereby a polymer with more ionisable groups should produce more protons when fully ionised. 
Nonetheless, this explanation is not viable as HP-50 has fewer groups (HP-50: 21.0-27.0%; HP-
55: 27.0-35.0%) therefore fewer protons would be produced, which is not the case as a higher 
number of protons are indeed being produced by HP-50. An additional and more plausible 
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explanation lies with the type of functional groups in these materials. Phthalate (the substituent 
present in HP-50 and HP-55) contains an aromatic ring. This group is prone to interact with other 
intra- and inter-molecular rings by π-π stacking, hindering the disentanglement of the polymeric 
chains during dissolution (López-Barrón and Zhou, 2017). During polymer dissolution, the medium 
diffuses through the polymer, creates a gel layer through which produced protons diffuse towards 
the bulk solution and where the disentanglement of the polymeric chains occurs (more details in 
Figure 1.7). A delay in the disentanglement caused by a higher presence of phthalate groups (such 
as in case of HP-55) leads to a slower dissolution (i.e. a slower production of protons), meaning a 
higher pHm after the 30 min of the test.  
A different story unfolds for AS-LF and AS-HF regarding the effect of the number and type of 
functional groups affecting the polymer dissolution. For these polymers, a higher dissolution rate 
was obtained for AS-LF, which also had a lower pHm. However, the % of functional groups is higher 
for AS-LF than for AS-HF (14.0-18.0% vs. 4.0-8.0%). This behaviour is contrary to that of HP, 
where the polymer with lowest % of functional groups had the highest dissolution rate and the 
lowest pHm. The obtained results are explained by the type of functional group and are in 
agreement with the pKa values, DpHT and obtained pHm for these polymers (Table 5.1).  
Firstly, in the case of AS-LF and AS-HF the difference in DpHT is much more than between HP-
50 and HP-55. AS-LF dissolves above pH 5.5, whereas AS-HF dissolves above pH 6.8 which 
immediately causes a distinction; for HPMC-AS it is the polymer with the highest % of functional 
groups which dissolves at lower pH values, to the opposite of HPMC-P. This issue has been 
addressed and the reason for this difference is discussed in more detail in Section 2.3.6.  
Secondly, it is also important to consider the pH at which all tests were conducted (pH 6.8), which 
corresponds to the DpHT of AS-HF. During polymer dissolution protons accumulate at the surface 
of the dissolving polymer, steadily decreasing the pH. For AS-HF even small increases in H+ can 
drop the pH below its DpHT, hindering its dissolution. As fewer protons are produced due to a 
lower dissolution rate, the equilibrium between generated and removed protons is eventually re-
established, and the pHm of the dissolving polymer stabilises, causing a higher pHm than for AS-
LF. The estimated pKa values for these polymers are very similar (AS-LF: 4.8; AS-HF 4.85), which 
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indicates that both these polymers should be nearly completely ionised at the pH used. However, 
the number of ionisable groups greatly differs between them, showing that, in the absence of 
additional hindering effects such as in the case of HP, more ionised groups lead to higher 
dissolution rates. The presence of more ionisable groups may increase the polymer’s 
hydrophilicity, as demonstrated by lower contact angle values for AS-LF, which in turn increases 
the affinity of the media to the polymer, improving wettability and causing higher dissolution rates. 
Results from pHm and dissolution rate measurements clearly demonstrate the importance not only 
of the buffer concentration, but of the buffer type and capacity.   
Table 5.1: Comparative table of measured parameters of importance in regulating polymer dissolution. 
Polymers % ionsable groups pKa DpHT 
pHm 
Phosphate Bicarbonate 
5mM 50mM 4.17mM 40mM 




















































DpHT: Dissolution pH threshold; pHm: Microenvironmental pH 
1: Shin-Etsu Chemical Co. (2002); 2: Shin-Etsu Chemical Co. (2018) 
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5.2. Future Works: New answers create new questions 
The use of dynamic light scattering allowed for the measurement of the pKa of different polymers, 
both natural and synthetic. The developed work showed how this technique can be used to study 
the ionisation behaviour of multiple polymers. Understanding how these polymers behave under 
different conditions would be the next step in this work, with both phosphate and bicarbonate 
buffers being the media to test. These two media types were tested throughout this thesis, with 
clear differences occurring with the two buffer types in polymer dissolution rates, 
microenvironmental pH, contact angles, among others. Therefore, it is important to address how 
these buffers influence the ionisation behaviour and ultimately the polymer dissolution.  
The reported studies further demonstrated the complexity of polymer dissolution under different 
conditions; yet, it was only applied to selected polymers. When these polymers are used, they are 
coated onto an oral solid dosage form, where the drug and other excipients are also present. It 
has been previously demonstrated that the acidity or alkalinity of a tablet core can have significant 
effect on the dissolution of the enteric coating. This can be the case with high dose weakly acidic 
or basic drugs  (Dangel et al., 2001; Dressman and Amidon, 1984; Ozturk et al., 1988a) or due to 
the presence of buffers or pH responsive excipients in the core which may modulate the dissolution 
of the coating both in-vitro (Liu et al., 2009) and in-vivo (Liu and Basit, 2010). These studies have 
demonstrated that the core is fully capable of buffering the polymeric layer, with more acidic cores 
leading to longer disintegration times of the coating (Dangel et al., 2001; Ozturk et al., 1988a) and 
less acidic cores leading to quicker drug releases (Liu et al., 2009). Therefore, future investigations 
aiming to directly study the dissolution of enteric coatings should consider the dissolution of both 
polymer and drug in the same system. Ultimately, a broader study of different polymer types 
(including acrylic enteric polymers) should be included to allow a better understanding of how and 
what affects polymer dissolution.  
Parallelly to different polymer types, the study of the effect of different types of drugs (acidic, basic 
or non-ionisable) on the pHm of dissolving polymers present in enteric solid dosage forms under 
biologically relevant conditions would present even deeper insights regarding polymer and drug 
dissolution in-vivo. To understand how the drug, the polymeric layer, the ionic strength, buffer type 
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and capacity of the medium affect the pHm and, indisputably, the dissolution of the polymer would 
be the apogee of decades of studies and would finally permit the design of the quintessential 
gastroresistant drug delivery system.  
The capsules produced in this thesis may very well be applied to such studies, facilitating the 
process of sample preparation, where a drug or excipients to be tested may be directly added to 
the capsule, ready for further studies in a very short time. As shown, the drug release from AS-LF 
and HP-55 capsules is in accordance with the dissolution rates obtained for these polymers, 
showing the reliability of these formulations for future studies. A process of tablet manufacturing 
and coating is thus avoided, and variables may be more easily controlled. Moreover, the enteric 
capsules can be further optimised to manipulate the drug release and target various pH thresholds 
by using a blend of multiple enteric polymers. The capsule size and shape can also be optimised 
for various age groups in clinic or for animal species used in drug delivery research or for veterinary 
applications.  
The next step in the productions of these capsules is to understand how different storage 
conditions may affect their stability and their enteric performance. A low water content may yield 
the capsules too brittle to handle or possibly excessive water may cause changes in the drug 
release profile due to enhanced diffusion. Additionally, it is important to also understand how the 
polymer type affects the formation of the capsules, and if polymers with different molecular weight 
would produce capsules with different properties. The final step would be assuring the scalability 
of this technology. Although the mechanics of the capsule formation are different from traditional 
gelatine capsules, the capsule production method is very similar, with the same dipping and drying 
steps. The key difference in this case would be to optimise drying conditions, to assure the 
polymeric film formation occurs at appropriate temperatures (accounting for the glass transition 
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